Item 8. Financial Statements
and Supplementary Data
Index to Consolidated Financial Statements Required by Article 8
of Regulation S-X:
Audited Financial Statements:
|
|
F-1
|
Report of Independent Registered Public Accounting Firm
|
F-2
|
Consolidated Balance Sheets as of December 31, 2015 and 2014
|
F-3
|
Consolidated Statements of Operations for the years ended December 31, 2015 and 2014
|
F-4
|
Consolidated Statement of Stockholders’ Equity (Deficit) for the two years in the period ended December 31, 2015
|
F-5
|
Consolidated Statements of Cash Flows for the years ended December 31, 2015 and 2014
|
F-6
|
Notes to Consolidated Financial Statements
|
Report of Independent Registered Public Accounting
Firm
To the Board of Directors and Shareholders of
Alkame Holdings, Inc.
We have audited the accompanying consolidated
balance sheet of Alkame Holdings, Inc. (the “Company”) as of December 31, 2015 and 2014, and the related consolidated
statements of operations, stockholders’ deficit and cash flows for the two years in the period ended December 31, 2015. These
consolidated financial statements are the responsibility of the Company’s management. Our responsibility is to express an
opinion on these consolidated financial statements based on our audits.
We conducted our audits in accordance with
the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform
the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. We were not
engaged to perform an audit of the Company’s internal control over financial reporting. Our audits included consideration
of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances,
but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting.
Accordingly, we express no such opinion. An audit also includes examining, on a test basis, evidence supporting the amounts and
disclosures in the financial statements, assessing the accounting principles used and significant estimates made by management,
and evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.
In our opinion, the consolidated financial
statements referred to above present fairly, in all material respects, the financial position of Alkame Holdings, Inc. at December 31,
2015 and 2014, and the results of its operations and its cash flows for the two years in the period ended December 31, 2015, in
conformity with accounting principles generally accepted in the United States of America.
The accompanying consolidated financial statements
have been prepared assuming that the Company will continue as a going concern. As discussed in Note 2 to the consolidated
financial statements, the Company has sustained net losses from operations and stockholder’s deficit. These conditions raise
substantial doubt about the Company’s ability to continue as a going concern. Management’s plans in regard to
these matters are also described in Note 2. The consolidated financial statements do not include any adjustments that might
result from the outcome of this uncertainty.
/s/ RBSM LLP
July 17, 2018
New York, New York
ALKAME HOLDINGS, INC. AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
|
|
December 31, 2015
|
|
December 31, 2014
|
ASSETS
|
|
|
|
|
|
|
|
Current assets:
|
|
|
|
|
|
|
|
Cash
|
|
$
|
—
|
|
|
$
|
172,730
|
Accounts receivable (net of reserve for bad debts of $161,000 and $23,000, respectively)
|
|
|
28,238
|
|
|
|
82,510
|
Other receivable
|
|
|
18,000
|
|
|
|
—
|
Prepaid expenses
|
|
|
7,000
|
|
|
|
260,000
|
Inventory
|
|
|
59,904
|
|
|
|
70,243
|
Total current assets
|
|
|
113,142
|
|
|
|
585,483
|
|
|
|
|
|
|
|
|
Fixed and intangible assets:
|
|
|
|
|
|
|
|
Manufacturing equipment, net
|
|
|
122,829
|
|
|
|
11,149
|
Software
|
|
|
11,997
|
|
|
|
17,995
|
Intangible assets, net
|
|
|
1,662
|
|
|
|
4,509
|
Fixed and intangible assets, net
|
|
|
136,488
|
|
|
|
33,653
|
|
|
|
|
|
|
|
|
Other assets:
|
|
|
|
|
|
|
|
Deferred finance costs
|
|
|
5,513
|
|
|
|
63,375
|
Investments
|
|
|
—
|
|
|
|
68,400
|
Total other assets
|
|
|
5,513
|
|
|
|
131,775
|
|
|
|
|
|
|
|
|
Total assets
|
|
$
|
255,143
|
|
|
$
|
750,911
|
|
|
|
|
|
|
|
|
LIABILITIES AND STOCKHOLDERS DEFICIT
|
|
|
|
|
|
|
|
Current liabilities:
|
|
|
|
|
|
|
|
Cash overdraft
|
|
$
|
2,448
|
|
|
$
|
—
|
Accounts payable and accrued expenses
|
|
|
727,290
|
|
|
|
304,530
|
Accrued interest
|
|
|
272,391
|
|
|
|
146,046
|
Accrued compensation
|
|
|
513,480
|
|
|
|
240,000
|
Customer deposits
|
|
|
17,170
|
|
|
|
—
|
Legal obligations
|
|
|
120,000
|
|
|
|
—
|
Loans from officer
|
|
|
26,456
|
|
|
|
3,489
|
Notes payable (net of debt discount of $35,095 and $0, respectively)
|
|
|
991,119
|
|
|
|
762,000
|
Note due Xtreme Shareholders
|
|
|
183,000
|
|
|
|
—
|
Convertible debentures (net of debt discount of $27,411 and $280,288, respectively)
|
|
|
552,479
|
|
|
|
168,961
|
Derivative instrument liability
|
|
|
1,046,635
|
|
|
|
1,018,782
|
Total current liabilities
|
|
|
4,452,468
|
|
|
|
2,643,808
|
|
|
|
|
|
|
|
|
Long-term liabilities:
|
|
|
|
|
|
|
|
Notes payable - long term
|
|
|
24,573
|
|
|
|
131,490
|
Convertible debt - long term (net of debt discount of $25,847 and $132,254, respectively)
|
|
|
29,486
|
|
|
|
22,968
|
Total long-term liabilities
|
|
|
54,059
|
|
|
|
154,458
|
|
|
|
|
|
|
|
|
Total liabilities
|
|
|
4,506,527
|
|
|
|
2,798,266
|
|
|
|
|
|
|
|
|
Commitments and contingencies
|
|
|
—
|
|
|
|
—
|
|
|
|
|
|
|
|
|
Stockholders’ deficit
|
|
|
|
|
|
|
|
Preferred stock - $0.001 par value, authorized - 100,000,000 shares;
|
|
|
|
|
|
|
|
Series A Convertible Preferred stock - $0.001 par value, 12,000,000 shares designated; issued and outstanding - 12,000,000 and 12,000,000 shares, respectively
|
|
|
12,000
|
|
|
|
12,000
|
Series B Preferred stock - $0.001 par value, 70,000,000 shares designated; issued and outstanding 65,398,334 and 65,398,334 shares, respectively
|
|
|
65,398
|
|
|
|
65,398
|
Series C Preferred stock - $0.001 par value, 10,000,000 shares designated; issued and outstanding 0 shares
|
|
|
—
|
|
|
|
—
|
Series D Preferred stock - $0.001 par value, 4,000,000 shares designated; issued and outstanding 2,000,000 and 0 shares, respectively
|
|
|
2,000
|
|
|
|
—
|
Common stock - $0.001 par value, authorized - 900,000,000 shares; issued and outstanding - 198,485,547 and 74,045,606 shares, respectively
|
|
|
198,486
|
|
|
|
74,046
|
Common stock to be issued
|
|
|
13,500
|
|
|
|
13,500
|
Series C Convertible Preferred Stock to be issued
|
|
|
1,425,000
|
|
|
|
—
|
Additional paid-in capital
|
|
|
7,010,488
|
|
|
|
6,259,050
|
Accumulated deficit
|
|
|
(12,978,256
|
)
|
|
|
(8,471,350)
|
Total stockholders' deficit
|
|
|
(4,251,384
|
)
|
|
|
(2,047,355)
|
|
|
|
|
|
|
|
|
Total liabilities and stockholders' deficit
|
|
$
|
255,143
|
|
|
$
|
750,911
|
See accompanying notes to the consolidated financial statements
ALKAME HOLDINGS, INC.
AND SUBSIDIARIES
CONSOLIDATED
STATEMENTS OF OPERATIONS
|
|
For the years ended
|
|
|
December 31, 2015
|
|
December 31, 2014
|
|
|
|
|
|
Revenues
|
|
$
|
898,381
|
|
|
$
|
143,321
|
|
|
|
|
|
|
|
|
Cost of goods sold
|
|
|
858,477
|
|
|
|
212,673
|
|
|
|
|
|
|
|
|
Gross profit (loss)
|
|
|
39,904
|
|
|
|
(69,352)
|
|
|
|
|
|
|
|
|
Operating expenses:
|
|
|
|
|
|
|
|
Selling expenses
|
|
|
585,352
|
|
|
|
939,618
|
General and administrative
|
|
|
1,211,139
|
|
|
|
592,055
|
Depreciation and amortization
|
|
|
136,523
|
|
|
|
2,844
|
Impairment of goodwill
|
|
|
658,187
|
|
|
|
—
|
Impairment of patents
|
|
|
928,572
|
|
|
|
—
|
Impairment customer list and trade names
|
|
|
343,750
|
|
|
|
—
|
Total operating expenses
|
|
|
3,863,524
|
|
|
|
1,534,517
|
|
|
|
|
|
|
|
|
Loss from operations
|
|
|
(3,823,620
|
)
|
|
|
(1,603,869)
|
|
|
|
|
|
|
|
|
Other (Income) / Expenses:
|
|
|
|
|
|
|
|
Amortization of deferred financing costs
|
|
|
81,194
|
|
|
|
665,955
|
Interest expense
|
|
|
182,242
|
|
|
|
121,919
|
Amortization of beneficial conversion feature
|
|
|
713,118
|
|
|
|
191,929
|
Gain on change in fair value of derivative liability
|
|
|
(289,994
|
)
|
|
|
414,311
|
Gain on extinguishment of debt
|
|
|
(28,904
|
)
|
|
|
—
|
Loss on disposition of terminated joint ventures
|
|
|
25,630
|
|
|
|
—
|
Total other expenses
|
|
|
683,286
|
|
|
|
1,394,114
|
|
|
|
|
|
|
|
|
Net loss applicable to common stock holders
|
|
$
|
(4,506,906
|
)
|
|
$
|
(2,997,983)
|
|
|
|
|
|
|
|
|
Per share data
|
|
|
|
|
|
|
|
Net Loss per share - basic and diluted
|
|
$
|
(0.03
|
)
|
|
$
|
(0.04)
|
|
|
|
|
|
|
|
|
Weighted average number of
|
|
|
|
|
|
|
|
shares outstanding- basic and diluted
|
|
|
149,785,191
|
|
|
|
75,924,202
|
|
|
|
|
|
|
|
|
See
accompanying notes to the consolidated financial statements
ALKAME HOLDINGS, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Series A Convertible Preferred Stock
|
|
Preferred B Stock
|
|
Preferred D Stock
|
|
Common Stock
|
|
|
|
|
|
|
|
|
|
|
($.001 par value)
|
|
($.001 par value)
|
|
($.001 par value)
|
|
($.001 par value)
|
|
|
|
|
|
|
|
|
|
|
Shares
|
|
Amount
|
|
Shares
|
|
Amount
|
|
Shares
|
|
Amount
|
|
Shares
|
|
Amount
|
|
Stock To be issued
|
|
Additional Paid-In Capital
|
|
Accumulated Deficit
|
|
Total Stockholders' Equity (Deficit)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance, January 1, 2014
|
|
|
12,000,000
|
|
|
$
|
12,000
|
|
|
|
—
|
|
|
$
|
—
|
|
|
|
—
|
|
|
$
|
—
|
|
|
|
135,089,766
|
|
|
$
|
135,090
|
|
|
$
|
—
|
|
|
$
|
5,548,405
|
|
|
$
|
(5,473,367
|
)
|
|
$
|
222,128
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance of stock for:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Conversion of common shares to Series B Convertible Preferred Shares
|
|
|
|
|
|
|
—
|
|
|
|
65,210,834
|
|
|
|
65,211
|
|
|
|
|
|
|
|
—
|
|
|
|
(65,210,834
|
)
|
|
|
(65,211
|
)
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
Issuance of common shares for commitment fees
|
|
|
|
|
|
|
—
|
|
|
|
|
|
|
|
—
|
|
|
|
|
|
|
|
—
|
|
|
|
4,166,674
|
|
|
|
4,167
|
|
|
|
|
|
|
|
620,833
|
|
|
|
—
|
|
|
|
625,000
|
|
Issuance of Series B Convertible Preferred Shares for placement fees
|
|
|
|
|
|
|
—
|
|
|
|
187,500
|
|
|
|
188
|
|
|
|
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
|
|
|
|
89,812
|
|
|
|
—
|
|
|
|
90,000
|
|
Common stock to be issued
|
|
|
|
|
|
|
—
|
|
|
|
|
|
|
|
—
|
|
|
|
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
13,500
|
|
|
|
—
|
|
|
|
—
|
|
|
|
13,500
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss
|
|
|
|
|
|
|
—
|
|
|
|
|
|
|
|
—
|
|
|
|
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
(2,997,983
|
)
|
|
|
(2,997,983
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance, December 31, 2014
|
|
|
12,000,000
|
|
|
|
12,000
|
|
|
|
65,398,334
|
|
|
|
65,398
|
|
|
|
—
|
|
|
|
—
|
|
|
|
74,045,606
|
|
|
|
74,046
|
|
|
|
13,500
|
|
|
|
6,259,050
|
|
|
|
(8,471,350
|
)
|
|
|
(2,047,355
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance of stock for:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Conversion of debentures and accrued interest
|
|
|
|
|
|
|
—
|
|
|
|
|
|
|
|
—
|
|
|
|
|
|
|
|
—
|
|
|
|
37,738,788
|
|
|
|
37,739
|
|
|
|
|
|
|
|
276,914
|
|
|
|
—
|
|
|
|
314,653
|
|
Settlement of accounts payable
|
|
|
|
|
|
|
—
|
|
|
|
|
|
|
|
—
|
|
|
|
|
|
|
|
—
|
|
|
|
86,701,153
|
|
|
|
86,701
|
|
|
|
|
|
|
|
416,523
|
|
|
|
—
|
|
|
|
503,224
|
|
Issuance of Series D Preferred Stock for employment and consulting services
|
|
|
|
|
|
|
—
|
|
|
|
|
|
|
|
—
|
|
|
|
2,000,000
|
|
|
|
2,000
|
|
|
|
|
|
|
|
—
|
|
|
|
|
|
|
|
58,000
|
|
|
|
|
|
|
|
60,000
|
|
Series C Convertible Preferred stock to be issued for the acquisition of Xtreme
|
|
|
|
|
|
|
—
|
|
|
|
|
|
|
|
—
|
|
|
|
|
|
|
|
—
|
|
|
|
|
|
|
|
—
|
|
|
|
1,425,000
|
|
|
|
—
|
|
|
|
—
|
|
|
|
1,425,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss
|
|
|
|
|
|
|
—
|
|
|
|
|
|
|
|
—
|
|
|
|
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
|
|
|
|
|
|
|
|
(4,506,906
|
)
|
|
|
(4,506,906
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance, December 31, 2015
|
|
|
12,000,000
|
|
|
$
|
12,000
|
|
|
|
65,398,334
|
|
|
$
|
65,398
|
|
|
|
2,000,000
|
|
|
$
|
2,000
|
|
|
|
198,485,547
|
|
|
$
|
198,486
|
|
|
$
|
1,438,500
|
|
|
$
|
7,010,488
|
|
|
$
|
(12,978,256
|
)
|
|
$
|
(4,251,384
|
)
|
See
accompanying notes to the consolidated financial statements
ALKAME HOLDINGS, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
|
|
For the years ended
|
|
|
December 31, 2015
|
|
December 31, 2014
|
Cash flows from operating activities:
|
|
|
|
|
|
|
|
Net loss
|
|
$
|
(4,506,906
|
)
|
|
$
|
(2,997,983)
|
Adjustments to reconcile net loss to net cash used in operating activities:
|
|
|
|
|
|
|
|
Bad debts
|
|
|
138,000
|
|
|
|
23,000
|
Depreciation and amortization
|
|
|
160,186
|
|
|
|
3,497
|
Common stock issued for services
|
|
|
—
|
|
|
|
625,000
|
Impairment of intangible assets
|
|
|
1,930,509
|
|
|
|
—
|
Amortization of debt discount – Xtreme
|
|
|
16,905
|
|
|
|
—
|
Amortization of beneficial conversion feature
|
|
|
713,118
|
|
|
|
191,929
|
Change in fair value of derivative liability
|
|
|
(289,994
|
)
|
|
|
414,310
|
Amortization of prepaid assets
|
|
|
253,000
|
|
|
|
634,500
|
Series D/B Convertible Preferred shares issued for services
|
|
|
60,000
|
|
|
|
90,000
|
Amortization of deferred financing costs
|
|
|
81,194
|
|
|
|
40,955
|
Gain on extinguishment of debt
|
|
|
(28,904
|
)
|
|
|
—
|
Loss on disposition of terminated joint ventures
|
|
|
25,630
|
|
|
|
—
|
Changes in operating asset and liability account balances:
|
|
|
|
|
|
|
|
Accounts receivable
|
|
|
(28,430
|
)
|
|
|
(105,179)
|
Other receivable
|
|
|
(17,654
|
)
|
|
|
—
|
Deposits
|
|
|
—
|
|
|
|
15,032
|
Inventory
|
|
|
85,519
|
|
|
|
(24,645)
|
Prepaid expenses
|
|
|
—
|
|
|
|
(10,000)
|
Accrued interest
|
|
|
160,167
|
|
|
|
109,699
|
Accounts payable and accrued expenses
|
|
|
750,356
|
|
|
|
481,833
|
Total adjustments
|
|
|
4,009,602
|
|
|
|
2,489,931
|
|
|
|
|
|
|
|
|
Net cash used in operating activities
|
|
|
(497,304
|
)
|
|
|
(508,052)
|
|
|
|
|
|
|
|
|
Cash flows from investing activities
|
|
|
|
|
|
|
|
Payment of purchase consideration to Xtreme Technologies, Inc.
|
|
|
(45,100
|
)
|
|
|
(54,900)
|
Cash acquired from Xtreme Technologies, Inc.
|
|
|
13,287
|
|
|
|
—
|
Funds spent on potential joint venture
|
|
|
(12,130
|
)
|
|
|
—
|
Purchase of equipment
|
|
|
(43,912
|
)
|
|
|
(29,798)
|
Net cash used in investing activities
|
|
|
(87,855
|
)
|
|
|
(84,698)
|
|
|
|
|
|
|
|
|
Cash flows from financing activities:
|
|
|
|
|
|
|
|
Cash overdraft
|
|
|
2,448
|
|
|
|
—
|
Proceeds from officer loans
|
|
|
22,967
|
|
|
|
—
|
Proceeds from notes payable
|
|
|
165,260
|
|
|
|
100,000
|
Payments of notes payable
|
|
|
(109,296
|
)
|
|
|
(10,000)
|
Proceeds from convertible notes
|
|
|
353,833
|
|
|
|
604,472
|
Payments of convertible notes
|
|
|
(22,783
|
)
|
|
|
(57,250)
|
Net cash provided by financing activities
|
|
|
412,429
|
|
|
|
637,222
|
|
|
|
|
|
|
|
|
Net (decrease) increase in cash
|
|
|
(172,730
|
)
|
|
|
44,472
|
|
|
|
|
|
|
|
|
Cash at beginning of year
|
|
|
172,730
|
|
|
|
128,258
|
|
|
|
|
|
|
|
|
Cash at end of year
|
|
$
|
—
|
|
|
$
|
172,730
|
|
|
|
|
|
|
|
|
Supplemental Schedule of Cash Flow Information:
|
|
|
|
|
|
|
|
Cash paid for interest
|
|
$
|
20,788
|
|
|
$
|
—
|
Cash paid for income taxes
|
|
$
|
—
|
|
|
$
|
—
|
|
|
|
|
|
|
|
|
Supplemental Schedules of Noncash Investing and Financing Activities:
|
|
|
|
|
|
|
|
Conversion of notes payable and accrued interest into common stock
|
|
$
|
314,653
|
|
|
$
|
—
|
Conversion of convertible loans and accrued interest to notes payable
|
|
$
|
36,400
|
|
|
$
|
—
|
Common stock to be issued for acquisition
|
|
$
|
—
|
|
|
$
|
13,500
|
Common stock issued to settle accounts payable
|
|
$
|
503,225
|
|
|
$
|
—
|
Payment made by EROP to noteholders on Company's behalf
|
|
$
|
342,000
|
|
|
$
|
—
|
Assets taken over and liabilities assumed from Xtreme Technologies, Inc.
|
|
$
|
2,050,000
|
|
|
$
|
—
|
Conversion of Common shares in Series B convertible preferred stock
|
|
$
|
—
|
|
|
$
|
65,211
|
Beneficial conversion feature on convertible debt
|
|
$
|
353,832
|
|
|
$
|
(191,929)
|
See
accompanying notes to the consolidated financial statements
Alkame Holdings, Inc. and Subsidiaries
Notes to the Consolidated Financial Statements
For the years ended December 31, 2015
and 2014
|
1.
|
Organization and Nature of Operations
|
Alkame Holdings, Inc. (fka Pinacle
Enterprise Inc.) (the "Company", “we”, “us” or “our”) was incorporated under the
laws of the State of Nevada on April 19, 2010. The Company is in the business of distributing bottled alkaline, antioxidant
and oxygenated water.
On June 24, 2013, the Company
entered into a share exchange agreement with Alkame Water, Inc. (“Alkame”) and the shareholders of all of the issued
and outstanding shares of Alkame. On June 25, 2013, the Company acquired 100% of the members’ shares of Alkame, a Company
incorporated in the state of Nevada on March 1, 2012, in exchange for 150,000,000 common shares, comprised of 116,666,667 common
shares privately transacted from the President of the Company and the issuance of 33,333,333 common shares to shareholders of Alkame.
Effectively, Alkame held 71% of the issued and outstanding common shares of the Company and the transaction has been accounted
for as a reverse merger, where Alkame is deemed to be the acquirer and or the surviving entity for accounting purposes.
As part of the acquisition transaction,
all assets and liabilities of Alkame Holdings, Inc. at the date of acquisition were assumed by the former management.
The transaction is accounted for
using the purchase method of accounting. As a result of the recapitalization and change in control, Alkame is the acquiring entity
in accordance with ASC 805, Business Combinations. Accordingly, the historical financial statements are those of Alkame, the accounting
acquirer, immediately following the consummation of the reverse merger.
As a result of the exchange transaction
in 2013, our board of directors decided to change our fiscal yearend from January 31 to December 31.
On April 21, 2014, we entered
into a Stock Purchase Definitive Agreement (the “Agreement”) with Xtreme Technologies, Inc., an Idaho corporation (“Xtreme”).
Pursuant to the terms of the Agreement, we agreed to acquire all of the issued and outstanding capital stock of Xtreme in exchange
for certain consideration as set forth in the Agreement.
On January 16, 2015, the parties
to the Agreement entered into an amendment (the “Amendment”) that changed, among other things, the Closing Date of
the transaction.
On April 15, 2015, the parties
to the Agreement entered into a second amendment (the “Second Amendment”) that changed, among other things, the 120-day
time period to pay monetary consideration under the Agreement to 240 days after the Closing Date of the transaction.
The accompanying consolidated
financial statements have been prepared using accounting principles generally accepted in the United States of America applicable
to a going concern, which contemplates the realization of assets and liquidation of liabilities in the normal course of business.
The Company has an accumulated deficit of $12,978,256 and has incurred a net loss of $4,506,906 for the year ended December 31,
2015. The Company's ability to continue as a going concern is dependent upon its ability to obtain the necessary financing to
meet its obligations and repay its liabilities arising from normal business operations when they become due, and to generate profitable
operations in the future. Management plans to continue to provide for its capital requirements by seeking long term financing
which may be in the form of additional equity securities and debt. The outcome of these matters cannot be predicted at this time
and there are no assurances that if achieved, the Company will have sufficient funds to execute its business plan or generate
positive operating results.
These matters, among others, raise
substantial doubt about the ability of the Company to continue as a going concern. These consolidated financial statements do not
include any adjustments to the amounts and classification of assets and liabilities that may be necessary should the Company be
unable to continue as a going concern.
|
3.
|
Summary of Significant Accounting Policies
|
a) Basis of
Presentation
The consolidated financial statements
of the Company have been prepared in accordance with accounting principles generally accepted in the United States (“US GAAP”)
and are expressed in U.S. dollars. All inter-company accounts and transactions have been eliminated. The Company’s fiscal
year end is December 31.
b) Principles of Consolidation
The consolidated financial statements
include the accounts of Alkame Holdings, Inc. (parent), Alkame Water, Inc., and Xtreme Technologies, Inc. our wholly owned subsidiaries
which have common ownership and management. All intercompany balances and transactions have been eliminated.
c) Use of Estimates
The preparation of financial statements
in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and
liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts
of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions related to the
deferred income tax asset valuation allowances. The Company bases its estimates and assumptions on current facts, historical experience
and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making
judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent
from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s
estimates. To the extent there are material differences between the estimates and the actual results, future results of operations
will be affected. Significant estimates included are assumptions about collection of accounts receivable, useful life of fixed
and intangible assets, impairment analysis of goodwill and intangible assets, estimates used in the fair value calculation of stock
based compensation, beneficial conversion feature and derivative liability on convertible notes and warrants using Black-Scholes
Model.
d) Cash and Cash
Equivalents
For purposes of the statement
of cash flows, cash includes demand deposits, saving accounts and money market accounts. The Company considers all highly liquid
instruments with maturities of three months or less when purchased to be cash equivalents.
e) Basic and Diluted
Net Loss per Share
The Company computes net loss
per share in accordance with ASC 260, Earnings per Share. ASC 260 requires presentation of both basic and diluted earnings per
share (“EPS”) on the face of the income statement. Basic EPS is computed by dividing net loss available to common
shareholders (numerator) by the weighted average number of shares outstanding (denominator) during the period. Diluted EPS gives
effect to all dilutive potential common shares outstanding during the period using the treasury stock method and convertible preferred
stock using the if-converted method. In computing diluted EPS, the average stock price for the period is used in determining the
number of shares assumed to be purchased from the exercise of stock options or warrants. Diluted EPS excludes all dilutive potential
shares if their effect is anti-dilutive.
|
|
As of December 31,
|
|
|
2015
|
|
2014
|
Series A Convertible Preferred Stock
|
|
|
600,000,000
|
|
|
|
600,000,000
|
Series B Convertible Preferred Stock
|
|
|
65,398,334
|
|
|
|
65,398,334
|
Series D Convertible Preferred Stock
|
|
|
20,000,000
|
|
|
|
—
|
3(a)10 Shares Issuances
|
|
|
691,349,500
|
|
|
|
—
|
Convertible notes payable
|
|
|
392,190,145
|
|
|
|
35,726,322
|
Warrants
|
|
|
1,587,302
|
|
|
|
1,587,302
|
f) Financial Instruments
Pursuant to ASC 820, Fair Value
Measurements and Disclosures, an entity is required to maximize the use of observable inputs and minimize the use of unobservable
inputs when measuring fair value. ASC 820 establishes a fair value hierarchy based on the level of independent, objective evidence
surrounding the inputs used to measure fair value. A financial instrument’s categorization within the fair value hierarchy
is based upon the lowest level of input that is significant to the fair value measurement. ASC 820 prioritizes the inputs into
three levels that may be used to measure fair value:
Level 1 applies to assets or liabilities
for which there are quoted prices in active markets for identical assets or liabilities.
Level 2 applies to assets or liabilities
for which there are inputs other than quoted prices that are observable for the asset or liability such as quoted prices for similar
assets or liabilities in active markets; quoted prices for identical assets or liabilities in markets with insufficient volume
or infrequent transactions (less active markets); or model-derived valuations in which significant inputs are observable or can
be derived principally from, or corroborated by, observable market data.
Level 3 applies to assets or liabilities
for which there are unobservable inputs to the valuation methodology that are significant to the measurement of the fair value
of the assets or liabilities.
The Company’s financial
instruments consist principally of cash, accounts payable and accrued liabilities and amounts due to related parties. Pursuant
to ASC 820, the fair value of our cash is determined based on “Level 1” inputs, which consist of quoted prices in active
markets for identical assets. We believe that the recorded values of all of our other financial instruments approximate their current
fair values because of their nature and respective maturity dates or durations.
g) Income Taxes
Potential benefits of income tax
losses are not recognized in the accounts until realization is more likely than not. The Company has adopted ASC 740 “Accounting
for Income Taxes” as of its inception. Pursuant to ASC 740, the Company is required to compute tax asset benefits for net
operating losses carried forward. The potential benefits of net operating losses have not been recognized in this financial statement
because the Company cannot be assured it is more likely than not it will utilize the net operating losses carried forward in future
years.
h) Revenue Recognition
The Company recognizes revenue
in accordance with ASC-605, “Revenue Recognition,” which requires that four basic criteria must be met before revenue
can be recognized: (1) persuasive evidence of an arrangement exists; (2) delivery has occurred or title has passed; (3) the selling
price is fixed and determinable; and (4) collectability is reasonably assured. Determination of criteria (3) and (4) are based
on management's judgments regarding the fixed nature of the selling prices of the products delivered and the collectability of
those amounts.
Revenues are recognized upon shipment,
provided that a signed purchase order has been received, the price is fixed, title has transferred, collection of resulting receivables
is reasonably assured, and there are no remaining significant obligations. Reserves for sales returns and allowances, including
allowances for so called “ship and debit” transactions, are recorded at the time of shipment, based on historical levels
of returns and discounts, current economic trends and changes in customer demand. Certain internet generated transactions that
are prepaid at time of order, are recognized at the time the merchandise ships from the warehouse to the customer.
Provisions for discounts and rebates
to customers, estimated returns and allowances, and other adjustments are provided for in the same period the related sales are
recorded. The Company will defer any revenue for which the product has not been delivered or is subject to refund until such time
that the Company and the customer jointly determine that the product has been delivered or no refund will be required.
i) Accounts receivable
and concentration of credit risk
Because the Company currently
uses distributors as their main source of product sales and placement, there is an inherent risk that the distributor could experience
difficulty in their payments for accounts they ship to. The result, may be that they, while collecting from the stores and chains
they supply, they do not process through the payments to us. Although in the past the Company did see significant credit risk associated
with the trade receivables, repayment is dependent upon the financial stability of the various distributors and customers to which
shipment takes place. As a result, the Company is looking more closely at the credit worthiness of its customer and how large a
footprint and customer base various distributors have, and is attempting to limit how much of our business is conducted through
any one customer or distributor. Our concentration risk will is being reevaluated on a quarterly basis.
j) Allowance for doubtful accounts
The allowance for doubtful accounts
is based on the Company’s assessment of the collectability of customer accounts and the aging of the accounts receivable.
The Company regularly reviews the adequacy of the Company’s allowance for doubtful accounts through identification
of specific receivables where it is expected that payments will not be received. The Company also establishes an unallocated
reserve that is applied to all amounts that are not specifically identified. In determining specific receivables where collections
may not have been received, the Company reviews past due receivables and gives consideration to prior collection history and changes
in the customer’s overall business condition. The allowance for doubtful accounts reflects the Company’s best
estimate as of the reporting dates.
At December 31, 2015 and 2014,
the Company had an allowance for bad debts in the amount of $161,000 and $23,000 respectively.
k) Related Party Transactions
The Company considers all officers,
directors, senior management personnel, and senior level consultants to be related parties to the Company.
l) Recent Accounting
Pronouncements
The FASB has issued ASU No. 2014-09,
Revenue from Contracts with Customers. This ASU supersedes the revenue recognition requirements in Accounting Standards Codification
605 - Revenue Recognition and most industry-specific guidance throughout the Codification. The standard requires that an entity
recognizes revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration
to which the company expects to be entitled in exchange for those goods or services. This ASU is effective on January 1, 2017 and
should be applied retrospectively to each prior reporting period presented or retrospectively with the cumulative effect of initially
applying the ASU recognized at the date of initial application.
In April 2016, the FASB issued
ASU 2016-10, Revenue from Contracts with Customers (Topic 606): Identifying Performance Obligations and Licensing, which provides
further guidance on identifying performance obligations and improves the operability and understandability of licensing implementation
guidance.
In March 2016, the FASB issued
ASU 2016-08, Revenue from Contracts with Customers (Topic 606): Principal versus Agent Considerations (Reporting Revenue Gross
versus Net) that clarifies how to apply revenue recognition guidance related to whether an entity is a principal or an agent. ASU
2016-08 clarifies that the analysis must focus on whether the entity has control of the goods or services before they are transferred
to the customer and provides additional guidance about how to apply the control principle when services are provided and when goods
or services are combined with other goods or services.
The effective date for ASU 2016-10
is the same as the effective date of ASU 2016-08 and ASU 2014-09 as amended by ASU 2015-14, for annual reporting periods beginning
after December 15, 2017, including interim periods within those years.
Effective
January 1, 2018, the Company will adopt the requirements of Topic 606 using the modified retrospective method. Upon adoption, the
Company will recognize the cumulative effect of initially applying the new revenue standard as an adjustment to the opening balance
of retained earnings. Using the modified retrospective method of adoption, the comparative information for periods prior to 2018
will not be restated and instead will continue to be reported under the accounting standards in effect for those periods.
The
Company anticipates that the adoption of the new standard will not result in a material difference between the recognition of revenue
under Topic 606 and prior accounting standards. In addition, to meet the disaggregation disclosure requirements under Topic 606,
the Company anticipates its disclosure of revenue disaggregation will be by major product group, geographic area and major sales
channels.
Share-Based Compensation: Modification
Accounting. In May 2017, the FASB issued an update to clarify when to account for a change to the terms or conditions of a share-based
payment award as a modification. Under the new guidance, modification accounting is required only if the fair value, the vesting
conditions, or the classification of the award changes as a result of the change in terms or conditions. This authoritative guidance
will be applied prospectively to awards modified following adoption and will be effective for Alkame in the first quarter of fiscal
2019 with early adoption permitted. The impact of the adoption of this guidance will depend on whether the Company has any share-based
payment awards or makes any future modifications of share-based payment awards.
Retirement Benefits. In March
2017, the FASB issued authoritative guidance which requires companies to present the service cost component of net benefit cost
in the same line items in which they report compensation cost. The other components of net benefit cost are required to be presented
in the income statement separately from the service cost component and outside a subtotal of income from operations, if one is
presented. The authoritative guidance will be effective for Alkame in the first quarter of fiscal 2019 on a retrospective basis,
with early adoption permitted. The adoption of this guidance is only expected to result in reclassification of other components
of net benefit costs outside of income from operations and is not expected to have a significant impact on Alkame’s consolidated
financial statements as the Company does not have such a plan at this time.
Business Combinations. In January
2017, the FASB issued authoritative guidance that clarifies the definition of a business to help companies evaluate whether acquisition
or disposal transactions should be accounted for as asset groups or as businesses. The authoritative guidance will be effective
for Alkame in the first quarter of fiscal 2019 on a prospective basis, with early adoption permitted. The impact of the adoption
depends on the facts and circumstances of future acquisition or disposal transactions.
Income Taxes: Intra-Entity Asset
Transfers. In October 2016, the FASB issued authoritative guidance that requires entities to recognize at the transaction date
the income tax consequences of intercompany asset transfers other than inventory. The authoritative guidance will be effective
for Alkame in the first quarter of fiscal 2019, with early adoption permitted. Alkame is currently evaluating the effect of this
new guidance on Alkame’s consolidated financial statements.
Classification of Certain Cash
Receipts and Cash Payments. In August 2016, the FASB issued authoritative guidance which addresses classification of certain cash
receipts and cash payments related to the statement of cash flows. The authoritative guidance will be effective for Alkame in the
first quarter of fiscal 2019. The adoption of this guidance is not expected to have a significant impact on Alkame’s consolidated
financial statements.
Share-Based Compensation. In March
2016, the FASB issued authoritative guidance that simplifies several aspects of the accounting for share-based payment transactions,
including the income tax consequences, forfeitures, classification of awards as either equity or liabilities, and classification
on the statement of cash flows. Alkame plans to adopt the authoritative guidance effective in the first quarter of fiscal 2018.
Upon adoption, Alkame will elect to continue to estimate forfeitures expected to occur to determine the amount of compensation
cost to be recognized in each period. The new standard will result in the recognition of excess tax benefits in provision for income
taxes rather than paid-in capital prospectively, which is expected to increase volatility in Alkame’s results of operations.
Alkame will elect to apply the presentation requirements for cash flows related to excess tax benefits retrospectively. The presentation
requirements for cash flows related to employee taxes paid for withheld shares will be presented as a financing activity retrospectively,
as required. Alkame expects cash flow from operations to increase, with a corresponding decrease in cash flow from financing activity
as a result of the changes in the cash flow presentation.
Leases. In February 2016, the
FASB issued authoritative guidance for lease accounting, which requires lessees to recognize lease assets and liabilities on the
balance sheet for certain lease arrangements that are classified as operating leases under the previous standard, and to provide
for enhanced disclosures. The authoritative guidance will be effective for Alkame in the first quarter of fiscal 2020 and should
see Alkame using a modified retrospective approach. Early adoption is permitted. Alkame is currently evaluating the effect of this
new guidance on Alkame’s consolidated financial statements.
Financial Instruments:
Classification and Measurement. In January 2016, the FASB issued authoritative guidance that requires equity investments that
do not result in consolidation, and are not accounted for under the equity method, to be measured at fair value, and requires
recognition of any changes in fair value in net income unless the investments qualify for a new practicability exception. For
financial liabilities measured at fair value, the change in fair value caused by a change in instrument-specific credit risk
will be required to be presented separately in other comprehensive income. The authoritative guidance will be effective for
Alkame in the first quarter of fiscal 2019. Early adoption is permitted only for the provisions related to the recognition of
changes in fair value of financial liabilities caused by instrument-specific credit risk. Alkame is currently evaluating the
effect of this new guidance on Alkame’s consolidated financial statements.
Inventory: In July 2015, the FASB
issued ASU No. 2015-11, Simplifying the Measurement of Inventory (Topic 330). ASU 2015-11 simplifies the accounting for the valuation
of all inventory not accounted for using the last-in, first-out (“LIFO”) method by prescribing that inventory be valued
at the lower of cost and net realizable value. ASU 2015-11 is effective for financial statements issued for fiscal years, and interim
periods within those fiscal years, beginning after December 15, 2016 on a prospective basis. Alkame is currently evaluating the
effect of this new guidance on Alkame’s consolidated financial statements.
The Company has implemented all
new accounting pronouncements that are in effect. These pronouncements did not have any material impact on the financial statements
unless otherwise disclosed, and the Company does not believe that there are any other new accounting pronouncements that have been
issued that might have a material impact on its financial position or results of operations.
m) Inventory
Inventories are stated at the
lower of cost or market, and consist of finished goods produced in accordance with Company specifications, work-in-process as such
may exist from time to time at various supplier locations that may work with Company supplied goods and materials, and raw materials
that are purchased in connection with upcoming seasonal production of goods.
n) Derivative Liabilities
The Company assessed the classification
of its derivative financial instruments as of December 31, 2015, which consist of convertible instruments and rights to shares
of the Company’s common stock, and determined that such derivatives meet the criteria for liability classification under
ASC 815.
ASC 815 generally provides three
criteria that, if met, require companies to bifurcate conversion options from their host instruments and account for them as free-standing
derivative financial instruments. These three criteria include circumstances in which (a) the economic characteristics and risks
of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host
contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured
at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings
as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative
instrument subject to the requirements of ASC 815. ASC 815 also provides an exception to this rule when the host instrument is
deemed to be conventional, as described.
o) Convertible Instruments
The Company evaluates and accounts
for conversion options embedded in its convertible instruments in accordance with professional standards for “Accounting
for Derivative Instruments and Hedging Activities”.
Professional standards generally
provide three criteria that, if met, require companies to bifurcate conversion options from their host instruments and account
for them as free standing derivative financial instruments. These three criteria include circumstances in which (a) the economic
characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics
and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract
is not re-measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value
reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would
be considered a derivative instrument. Professional standards also provide an exception to this rule when the host instrument is
deemed to be conventional as defined under professional standards as “The Meaning of “Conventional Convertible Debt
Instrument”.
The Company accounts for convertible
instruments (when it has determined that the embedded conversion options should not be bifurcated from their host instruments)
in accordance with professional standards when “Accounting for Convertible Securities with Beneficial Conversion Features,”
as those professional standards pertain to “Certain Convertible Instruments.” Accordingly, the Company records, when
necessary, discounts to convertible notes for the intrinsic value of conversion options embedded in debt instruments based upon
the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective
conversion price embedded in the note. Debt discounts under these arrangements are amortized over the term of the related debt
to their earliest date of redemption. The Company also records when necessary deemed dividends for the intrinsic value of conversion
options embedded in preferred shares based upon the differences between the fair value of the underlying common stock at the commitment
date of the note transaction and the effective conversion price embedded in the note.
ASC 815-40 provides that, among
other things, generally, if an event is not within the entity’s control could or require net cash settlement, then the contract
shall be classified as an asset or a liability.
p) Long Lived Assets
The Company follows Accounting
Standards Codification subtopic 360-10, Property, Plant and Equipment (“ASC 360-10”). ASC 360-10 requires those long-lived
assets and certain identifiable intangibles held and used by the Company be reviewed for impairment whenever events or changes
in circumstances indicate that the carrying amount of an asset may not be recoverable. Events relating to recoverability may include
significant unfavorable changes in business conditions, recurring losses, or a forecasted inability to achieve break-even operating
results over an extended period. The Company evaluates the recoverability of long-lived assets based upon forecasted undiscounted
cash flows. Should impairment in value be indicated, the carrying value of intangible assets will be adjusted, based on estimates
of future discounted cash flows resulting from the use and ultimate disposition of the asset. ASC 360-10 also requires assets to
be disposed of be reported at the lower of the carrying amount or the fair value less costs to sell.
q) Advertising
Advertising is expensed as incurred
and is included in selling costs on the accompanying consolidated statements of operations. Advertising and marketing expense for
the years ended December 31, 2015 and 2014 was $22,728 and $17,331, respectively.
r) Shipping costs
Shipping costs are included in
cost of goods sold and totaled $272,124 and $50,572 for the years ended December 31, 2015 and 2014, respectively.
|
4.
|
Acquisition of Xtreme Technologies
|
On April 21, 2014, we entered into
a Stock Purchase Definitive Agreement (the “Agreement”) with Xtreme Technologies, Inc., an Idaho corporation (“Xtreme”).
Pursuant to the terms of the Agreement, we agreed to acquire all of the issued and outstanding capital stock of Xtreme in exchange
for certain consideration as set forth in the Agreement.
On January 16, 2015, the parties
to the Agreement entered into an amendment (the “Amendment”) that changed, among other things, the Closing Date of
the transaction.
On April 15, 2015, the parties to
the Agreement entered into a second amendment (the “Second Amendment”) that changed, among other things, the 120-day
time period to pay monetary consideration under the Agreement to 240 days after the Closing Date of the transaction.
In accordance with the terms of
the Agreement, the Amendment and the Second Amendment, we agreed to purchase all of the outstanding shares of Xtreme for the purchase
price of $2,000,000, payable as follows:
|
|
§
|
A cash payment of $50,000 has been previously paid as a non-refundable
deposit;
|
|
|
§
|
The Closing Date is effective as of January 13, 2015;
|
|
|
§
|
An additional cash payment of $525,000 shall be paid within two hundred
and forty (240) days of the Closing Date, which, along with the initial $50,000 deposit, shall pay the obligations on Xtreme’s
balance sheet;
|
|
|
§
|
The balance of $1,425,000 shall be payable by the issuance of shares
of the Company’s Series B Preferred Stock to be divided
pro rata
among the Company’s shareholders of record
as of the Closing Date. The Series B Preferred Stock shall include an option to convert each share of Series B Preferred Stock
into one share of the Company’s Common Stock. The Series B Preferred Stock shall be held in escrow along with the issued
and outstanding shares of Xtreme’s capital stock pending the full payment of $525,000. As of the date of this report, the
balance of $525,000 has been fully paid to Xtreme; and
|
|
|
§
|
One of Xtreme’s previous officers and directors holds outstanding
options to purchase up to 1,009,000 shares of Xtreme’s common stock at the price of $0.10 per share. At the Closing Date,
pursuant to Idaho law, Xtreme shall notify this previous officer and director of his 30-day right to exercise any or all of his
remaining options. If he elects to exercise any of his options within such 30-day period, the Company agrees to issue additional
shares of Series B Preferred Stock in exchange for such Xtreme shares. Xtreme notified the option holder and the 30-day period
expired unanswered. The options expired unexercised.
|
Th
e
Amendment also requires that the Company guarantee the obligations on employment agreements for Xtreme’s key employees,
namel
y, Keith Fuqua, Timm Ott and Casey Henry. The employment agreements with Messrs. Fuqua, Ott and Henry have the terms
set forth in the following table.
Employee
|
Position
|
Term
|
Compensation
|
Commission
|
Benefits
|
Severance
|
Keith Fuqua
|
Operations Director
|
One year
|
$70,000 annually and annual bonus
|
5% on gross sales made to Walmart
|
Benefit plans
|
6 months’ severance for termination in certain instances; residual commissions for 1 year
|
Timm Ott
|
Sales and Marketing Director and Treasurer
|
One year
|
$2,700 per month salary and annual bonus
|
$1.00 per case of product sold
|
Benefit plans
|
6 months’ severance for termination in certain instances
|
Casey Henry
|
Manufacturing Director
|
One year
|
$4,350 per month and annual bonus
|
$1.00 per case of product sold
|
Benefit plans
|
6 months’ severance for termination in certain instances
|
In addition, after the Closing
Date, Xtreme’s current officers and directors, namely, Jeffery J. Crandall, John N. Marcheso and Michael J. Bibin, shall
continue to serve in that capacity until the $525,000 is paid in full. Our President and CEO, Robert K. Eakle and two (2) additional
representatives of our company shall be appointed as directors of Xtreme and shall serve together with the other directors until
the $525,000 is paid in full. In addition, Mr. Eakle shall be named as President and Chief Executive Officer of Xtreme. Until the
$525,000 is paid in full, the officers and directors of Xtreme shall not make any material change in the company’s business
and operations without unanimous consent of the directors. If the $525,000 is not paid in full within two hundred and forty (240)
days of the Closing Date, as may be extended, then the appointments of Mr. Eakle and the other two representatives as interim officers
and directors shall be terminated. Upon payment of $525,000 in full to Xtreme, all former officers and directors of Xtreme shall
resign and full control of Xtreme shall be tendered to us. Provided that certain representations are accurate, Jeffery J. Crandall,
John N. Marcheso and Michael J. Bibin shall be released by us and Xtreme from any liability as officers and directors of Xtreme
for their fiduciary obligations occurring prior to the Closing Date. As of the date of this filing, the entire payment has been
made.
We previously held a three-year
limited exclusive distribution agreement with Xtreme for the consumer market. We were permitted to distribute the technologically
enhanced bottled water in the consumer market in the United States, Canada and Mexico. As a result of the Agreement, Amendment,
and Second Amendment, Xtreme became our wholly-owned subsidiary and we acquired the patents on the proprietary process that we
believe is the most technologically advanced in water treatment systems for complete hydration. We will now assume the operations
of Xtreme and continue its business of distributing technologically enhanced bottled water.
Upon closing of the acquisition,
we discovered that Xtreme was operating at a loss for the prior year and that it required a substantial cash infusion. We began
a program of upgrading the production line, reorganized personnel, and began an effort to increase sales of the division so that
it returns to profitability as quickly as possible. However, as 2015 progressed, it became obvious that changes in contracts negotiated
prior to our acquisition were no longer profitable and we terminated the agreements with those customers.
Our primary objective now is
to introduce, promote, aggressively market and establish channels of distribution to sell our product to a wide range of consumers,
first in the United States, Canada and Mexico, and then globally. In addition, the Company is moving in the direction of bottling
or “co-packing”.
Alkame Holdings, Inc.
Xtreme Technologies, Inc.
Asset Acquired & Liabilities Assumed
January 14, 2015
|
|
Assets
|
|
Liabilities
|
|
2015
Impairment
|
Cash
|
|
$
|
13,287
|
|
|
$
|
|
|
|
$
|
|
Receivables
|
|
|
55,644
|
|
|
|
|
|
|
|
|
Inventory
|
|
|
75,180
|
|
|
|
|
|
|
|
|
Fixed
Assets
|
|
|
91,431
|
|
|
|
|
|
|
|
|
Patent
Costs
|
|
|
1,000,000
|
|
|
|
|
|
|
|
1,000,000
|
Customer
List
|
|
|
250,000
|
|
|
|
|
|
|
|
250,000
|
Trade
Names
|
|
|
150,000
|
|
|
|
|
|
|
|
150,000
|
Goodwill
|
|
|
658,187
|
|
|
|
|
|
|
|
658,187
|
Accounts
Payable & Accrued Liabilities
|
|
|
|
|
|
|
243,729
|
|
|
|
|
Purchase
consideration (Cash $625,000 and Series C Convertible Preferred Stock to be issued $1,425,000)
|
|
|
|
|
|
|
2,050,000
|
|
|
|
|
|
|
$
|
2,293,729
|
|
|
$
|
2,293,729
|
|
|
$
|
2,058,187
|
As of the date of this filing, the
Company has closed down this division, and written the asset values off in their entirety.
|
5.
|
Notes Payable, current and long-term
|
At December 31, 2015 and 2014, notes payable
consisted of the following:
|
|
December 31, 2015
|
|
December 31, 2014
|
Notes payable - current
|
|
$
|
1,050,787
|
|
|
$
|
893,490
|
Note payable Xtreme shareholders
|
|
|
183,000
|
|
|
|
—
|
Officer loans
|
|
|
26,456
|
|
|
|
3,489
|
Unamortized debt discount
|
|
|
(35,095
|
)
|
|
|
—
|
Carrying amount
|
|
$
|
1,225,148
|
|
|
$
|
896,979
|
Less: current portion
|
|
|
(1,200,575
|
)
|
|
|
(765,489)
|
Long-term notes payable, net
|
|
$
|
24,573
|
|
|
$
|
131,490
|
Current
:
During the year ended December
31, 2013, the Company had $63,000 in expenses paid on its behalf by this shareholder and former director which was recorded as
a Note. On August 1, 2013, the Company and Note Holder amended the Note by mutual agreement increasing the principal amount by
an additional $10,000 for other services rendered by the former director. The Note is unsecured, and only began accruing
interest August 1, 2014 at 5% per annum on the unpaid principal thereof.
During the years ended December
31, 2015 and 2014, the Company repaid $10,000 and $10,000 of the Note respectively.
At December 31, 2015 and 2014,
the balance of the Note was $36,573 and $43,490, respectively.
Long-term
:
On March 29, 2013, the Company
entered into a two-year promissory note agreement for $500,000. On April 8, 2013, the Company received $200,000 and on May 1, 2013,
the Company received $300,000. On September 27, 2013, the note agreement was amended to include an additional advance to the Company
of $250,000. Pursuant to the agreement, the loan is secured with a general security agreement, bears interest at 10% per
annum, and $500,000 was due on March 30, 2015 and $250,000 is due on September 27, 2015. The original note, and the amendment,
each mature two years from date of issuance or amendment. The payment due March 30, 2015 has not been declared in default, and
the Company was in settlement discussions with the lender.
On March 11, 2014, the Company
entered into an additional two-year promissory note agreement for an additional $100,000 from the same investor group, on the same
terms as outlined above.
As of December 31, 2015, the Company
classified $850,000 of this note payable to current liability.
The Company paid 10% of proceeds
from $750,000 of the long-term notes payable as financing cost of $75,000 to a consultant. The Company will amortize this cost
over the term of the long-term note payable.
The Company paid 10% of proceeds
from the $100,000 long-term notes payable as financing cost of $10,000 to a consultant. The Company will amortize this cost over
the term of the long-term note payable.
During the years ended December
31, 2015 and 2014, the Company charged to operations $81,194 and $665,955 as amortization of deferred financing costs, respectively.
As of December 31, 2015, and 2014, remaining balance in deferred financing cost of $5,513 and $63,375, respectively is presented
as part of other assets.
In July 2015, the
Company borrowed $70,000 from an accredited investor group on a term loan. The note carries interest at 15% per annum and requires
repayment of a total of $98,000 through daily payments of $560.
In July 2015, the
Company borrowed $25,000 from an accredited investor group on a term loan. The note carries prepaid interest of 10% of the amount
borrowing.
In August 2015, the Company borrowed
$50,000 from an accredited investor group on a term loan. The note carries interest at 15% per annum and requires repayment of
a total of $74,500 through daily payments of $899.
At December 31, 2015 and 2014 convertible
notes and debentures consisted of the following:
|
|
December 31, 2015
|
|
December 31, 2014
|
Convertible notes payable
|
|
$
|
635,223
|
|
|
$
|
604,472
|
Unamortized debt discount
|
|
|
(53,258
|
)
|
|
|
(412,542)
|
Carrying amount
|
|
$
|
581,965
|
|
|
$
|
191,930
|
Less: current portion
|
|
|
(552,479
|
)
|
|
|
(168,962)
|
Long-term convertible notes, net
|
|
$
|
29,486
|
|
|
$
|
22,968
|
Note issued on August 6, 2014,
fully converted:
On August 6, 2014, the Company entered
into a one-year convertible debenture for $82,500 with an accredited institutional investor. The debenture was convertible at the
lesser of $0.10 per share, or 60% of the lowest trade price in the 25 trading days prior to conversion. The note was issued with
an original issue discount of $7,500 which was charged to current period operations as interest expense during the year ended December
31, 2014.
The Company identified embedded
derivatives related to the Convertible Promissory Notes entered into in August 2014. These embedded derivatives included
certain conversion features. The accounting treatment of derivative financial instruments requires that the Company record
the fair value of the derivatives as of the inception date of the Convertible Promissory Note and to adjust the fair value as of
each subsequent balance sheet date. At the inception of the Convertible Promissory Note, the Company determined a fair value
of $190,451 of the embedded derivative. The fair value of the embedded derivative was determined using the Black-Scholes Model
based on the following assumptions:
Dividend yield:
|
|
|
0
|
%
|
Volatility
|
|
|
105
|
%
|
Risk free rate:
|
|
|
0.48
|
%
|
The initial fair values of the embedded
debt derivative of $190,451 was allocated as a debt discount up to the proceeds of the note ($82,500) with the remainder ($107,951)
charged to operations as derivative liability adjustment in during the year ended December 31, 2014.
During the year ended December 31,
2014, the Company amortized $17,187 to current period operations as amortization of beneficial conversion feature.
During the year ended December 31,
2015, the Company amortized the remaining $65,313 to the current period operations as amortization of beneficial conversion feature
upon full conversion of the debenture.
At December 31, 2015, due to full
conversion of the debenture, the Company adjusted the recorded fair value of the derivative liability to $0 resulting in non-cash,
non-operating gain of $142,317 for the year ended December 31, 2015.
Note issued on August 6, 2014,
fully converted:
On August 6, 2014, the Company entered
into a nine-month convertible debenture for $68,000 with an accredited institutional investor. The debenture is convertible at
58% of the average of the three lowest trading prices in the 10 trading days prior to conversion.
The Company identified embedded
derivatives related to the Convertible Promissory Notes entered into in August 2014. These embedded derivatives included
certain conversion features. The accounting treatment of derivative financial instruments requires that the Company record
the fair value of the derivatives as of the inception date of the Convertible Promissory Note and to adjust the fair value as of
each subsequent balance sheet date. At the inception of the Convertible Promissory Note, the Company determined a fair value
of $94,657 of the embedded derivative. The fair value of the embedded derivative was determined using the Black-Scholes Model
based on the following assumptions:
Dividend yield:
|
|
|
0
|
%
|
Volatility
|
|
|
105
|
%
|
Risk free rate:
|
|
|
0.48
|
%
|
The initial fair values of the embedded
debt derivative of $94,657 was allocated as a debt discount up to the proceeds of the note ($68,000) with the remainder ($32,145)
charged to operations as derivative liability adjustment during the year ended December 31, 2014.
During the year ended December 31,
2014, the Company amortized $37,778 to current period operations as amortization of beneficial conversion feature.
During the year ended December 31,
2015, the Company amortized the remaining $30,222 to the current period operations as amortization of beneficial conversion feature
upon full conversion of the debenture.
At December 31, 2015, due to full
conversion of the debenture, the Company adjusted the recorded fair value of the derivative liability to $0 resulting in non-cash,
non-operating gain of $90,253 for the year ended December 31, 2015.
Note issued on August 11,
2014, fully converted:
On August 11, 2014, the Company
entered into a five-month convertible debenture for $45,000 with an accredited institutional investor. The debenture is convertible
at 50% of the lowest traded price in the 20 days prior to the conversion.
The Company identified embedded
derivatives related to the Convertible Promissory Notes entered into in August 2014. These embedded derivatives included
certain conversion features. The accounting treatment of derivative financial instruments requires that the Company record
the fair value of the derivatives as of the inception date of the Convertible Promissory Note and to adjust the fair value as of
each subsequent balance sheet date. At the inception of the Convertible Promissory Note, the Company determined a fair value
of $131,493 of the embedded derivative. The fair value of the embedded derivative was determined using the Black-Scholes Model
based on the following assumptions:
Dividend yield:
|
|
|
0
|
%
|
Volatility
|
|
|
111
|
%
|
Risk free rate:
|
|
|
0.05
|
%
|
The initial fair values of the embedded
debt derivative of $131,493 was allocated as a debt discount up to the proceeds of the note ($45,000) with the remainder ($86,493)
charged to operations as derivative liability adjustment during the year ended December 31, 2014.
During the year ended December 31,
2014, the Company amortized $37,500 to current period operations as amortization of beneficial conversion feature.
During the year ended December 31,
2015, the Company amortized the remaining $7,500 to the current period operations as amortization of beneficial conversion feature
upon full conversion of the debenture.
At December 31, 2015, due to full
conversion of the debenture, the Company adjusted the recorded fair value of the derivative liability to $0 resulting in non-cash,
non-operating gain of $58,401 for the year ended December 31, 2015.
Note issued on September 4,
2014, fully converted:
On September 4, 2014, the Company
entered into a nine-month convertible debenture for $42,500 with an accredited institutional investor. The debenture is convertible
at 58% of the average of the three lowest trading prices in the 10 trading days prior to conversion.
The Company identified embedded
derivatives related to the Convertible Promissory Notes entered into in September 2014. These embedded derivatives included
certain conversion features. The accounting treatment of derivative financial instruments requires that the Company record
the fair value of the derivatives as of the inception date of the Convertible Promissory Note and to adjust the fair value as of
each subsequent balance sheet date. At the inception of the Convertible Promissory Note, the Company determined a fair value
of $52,597 of the embedded derivative. The fair value of the embedded derivative was determined using the Black-Scholes Model
based on the following assumptions:
Dividend yield:
|
|
|
0
|
%
|
Volatility
|
|
|
131
|
%
|
Risk free rate:
|
|
|
0.48
|
%
|
The initial fair values of the embedded
debt derivative of $52,597 was allocated as a debt discount up to the proceeds of the note ($42,500) with the remainder ($10,097)
charged to operations as derivative liability adjustment during the year ended December 31, 2014.
During the year ended December 31,
2014, the Company amortized $18,889 to current period operations as amortization beneficial conversion feature.
During the year ended December 31,
2015, the Company amortized the remaining $23,611 to the current period operations as amortization of beneficial conversion feature
upon full conversion of the debenture.
At December 31, 2015, due to full
conversion of the debenture, the Company adjusted the recorded fair value of the derivative liability to $0 resulting in non-cash,
non-operating gain of $59,207 for the year ended December 31, 2015.
Note issued on September 5,
2014:
On September 5, 2014, the Company
entered into a one-year convertible debenture for $52,500 with an accredited institutional investor. The debenture is convertible
at 53% of the lowest trading price in the 20 trading days prior to the conversion.
The Company identified embedded
derivatives related to the Convertible Promissory Notes entered into in September 2014. These embedded derivatives included
certain conversion features. The accounting treatment of derivative financial instruments requires that the Company record
the fair value of the derivatives as of the inception date of the Convertible Promissory Note and to adjust the fair value as of
each subsequent balance sheet date. At the inception of the Convertible Promissory Note, the Company determined a fair value
of $578,343 of the embedded derivative. The fair value of the embedded derivative was determined using the Black-Scholes Model
based on the following assumptions:
Dividend yield:
|
|
|
0
|
%
|
Volatility
|
|
|
166
|
%
|
Risk free rate:
|
|
|
0.10
|
%
|
The initial fair values of the embedded
debt derivative of $578,343 was allocated as a debt discount up to the proceeds of the note ($52,500) with the remainder ($525,843)
charged to operations as derivative liability adjustment during the year ended December 31, 2014.
During the year ended December 31,
2014, the Company amortized $17,500 to current period operations as amortization of beneficial conversion feature.
During the year ended December 31,
2015, the Company amortized $35,000 to current period operations as amortization of beneficial conversion feature.
The fair value of the described
embedded derivative of $89,087 at December 31, 2015 was determined using the Black-Scholes Model with the following assumptions:
Dividend yield:
|
|
|
0
|
%
|
Volatility
|
|
|
279
|
%
|
Risk free rate:
|
|
|
0.16
|
%
|
At December 31, 2015, the Company
adjusted the recorded fair value of the derivative liability to market resulting in non-cash, non-operating gain of $1,089 for
the year ended December 31, 2015.
Note issued on September 11,
2014, fully converted:
On September 11, 2014, the Company
entered into a nine-month convertible debenture for $56,250 with an accredited institutional investor. The debenture is convertible
at 55% of the average of the two lowest trading price in the 25 trading days prior to conversion.
The Company identified embedded
derivatives related to the Convertible Promissory Notes entered into in September 2014. These embedded derivatives included
certain conversion features. The accounting treatment of derivative financial instruments requires that the Company record
the fair value of the derivatives as of the inception date of the Convertible Promissory Note and to adjust the fair value as of
each subsequent balance sheet date. At the inception of the Convertible Promissory Note, the Company determined a fair value
of $300,489 of the embedded derivative. The fair value of the embedded derivative was determined using the Black-Scholes Model
based on the following assumptions:
Dividend yield:
|
|
|
0
|
%
|
Volatility
|
|
|
240
|
%
|
Risk free rate:
|
|
|
0.11
|
%
|
The initial fair values of the embedded
debt derivative of $300,489 was allocated as a debt discount up to the proceeds of the note ($56,250) with the remainder ($244,239)
charged to operations as derivative liability adjustment during the year ended December 31, 2014.
During the year ended December 31,
2014, the Company amortized $25,000 to current period operations as amortization of beneficial conversion feature.
During the year ended December 31,
2015, the Company amortized the remaining $31,250 to the current period operations as amortization of beneficial conversion feature
upon full conversion of the debenture.
At December 31, 2015, due to full
conversion of the debenture, the Company adjusted the recorded fair value of the derivative liability to $0 resulting in non-cash,
non-operating gain of $84,645 for the year ended December 31, 2015.
Note issued on October 24,
2014:
On October 24, 2014, the Company
entered into a twelve-month convertible debenture for $55,000 with an accredited institutional investor. The debenture is convertible
at 60% of the lowest closing price in the 20 trading days prior to conversion. The note was issued with an original issue discount
of $5,000 which was recorded as part of deferred financing cost and amortized over the term of the note.
The Company identified embedded
derivatives related to the Convertible Promissory Notes entered into in October 2014. These embedded derivatives included
certain conversion features. The accounting treatment of derivative financial instruments requires that the Company record
the fair value of the derivatives as of the inception date of the Convertible Promissory Note and to adjust the fair value as of
each subsequent balance sheet date. At the inception of the Convertible Promissory Note, the Company determined a fair value
of $162,550 of the embedded derivative. The fair value of the embedded derivative was determined using the Black-Scholes Model
based on the following assumptions:
Dividend yield:
|
|
|
0
|
%
|
Volatility
|
|
|
260
|
%
|
Risk free rate:
|
|
|
0.11
|
%
|
The initial fair values of the
embedded debt derivative of $162,550 was allocated as a debt discount up to the proceeds of the note ($55,000) with the remainder
($107,550) charged to operations as derivative liability adjustment during the year ended December 31, 2014.
During the year ended December
31, 2014, the Company amortized $13,750 to current period operations as amortization of beneficial conversion feature.
During the year ended December
31, 2015, the Company amortized $41,250 to current period operations as amortization of beneficial conversion feature.
The fair value of the described
embedded derivative of $79,536 at December 31, 2015 was determined using the Black-Scholes Model with the following assumptions:
Dividend yield:
|
|
|
0
|
%
|
Volatility
|
|
|
279
|
%
|
Risk free rate:
|
|
|
0.16
|
%
|
At December 31, 2015, the Company
adjusted the recorded fair value of the derivative liability to market resulting in non-cash, non-operating gain of $5,679 for
the year ended December 31, 2015.
Note issued on October 27,
2014:
On October 27, 2014, the Company
entered into a two-year convertible debenture for $33,000 with an accredited institutional investor. The debenture is convertible
at lesser of (a) $0.15 or (b) 60% of the lowest trading price in the 25 trading days prior to conversion. The note was issued with
an original issue discount of $3,000 which was recorded as part of deferred financing cost and amortized over the term of the note.
The Company identified embedded
derivatives related to the Convertible Promissory Notes entered into in October 2014. These embedded derivatives included
certain conversion features. The accounting treatment of derivative financial instruments requires that the Company record
the fair value of the derivatives as of the inception date of the Convertible Promissory Note and to adjust the fair value as of
each subsequent balance sheet date. At the inception of the Convertible Promissory Note, the Company determined a fair value
of $100,870 of the embedded derivative. The fair value of the embedded derivative was determined using the Black-Scholes Model
based on the following assumptions:
Dividend yield:
|
|
|
0
|
%
|
Volatility
|
|
|
260
|
%
|
Risk free rate:
|
|
|
0.41
|
%
|
The initial fair values of the
embedded debt derivative of $100,870 was allocated as a debt discount up to the proceeds of the note ($33,000) with the remainder
($67,870) charged to operations as derivative liability adjustment during the year ended December 31, 2014.
During the year ended December
31, 2014, the Company amortized $4,125 to current period operations as amortization of beneficial conversion feature.
During the year ended December
31, 2015, the Company amortized $16,500 to current period operations as amortization of beneficial conversion feature.
The fair value of the described
embedded derivative of $70,237 at December 31, 2015 was determined using the Black-Scholes Model with the following assumptions:
Dividend yield:
|
|
|
0
|
%
|
Volatility
|
|
|
279
|
%
|
Risk free rate:
|
|
|
0.65
|
%
|
At December 31, 2015, the Company
adjusted the recorded fair value of the derivative liability to market resulting in non-cash, non-operating loss of $12,490 for
the year ended December 31, 2015.
Note issued on October 29,
2014:
On October 29, 2014, the Company
entered into a twelve-month convertible debenture for $55,000 with an accredited institutional investor. The debenture is convertible
at lesser of (a) $0.10 or (b) 60% of the lowest trading price in the 25 trading days prior to conversion. The note was issued with
an original issue discount of $5,000 which was recorded as part of deferred financing cost and amortized over the term of the note.
The Company identified embedded
derivatives related to the Convertible Promissory Notes entered into in October 2014. These embedded derivatives included
certain conversion features. The accounting treatment of derivative financial instruments requires that the Company record
the fair value of the derivatives as of the inception date of the Convertible Promissory Note and to adjust the fair value as of
each subsequent balance sheet date. At the inception of the Convertible Promissory Note, the Company determined a fair value
of $142,870 of the embedded derivative. The fair value of the embedded derivative was determined using the Black-Scholes Model
based on the following assumptions:
Dividend yield:
|
|
|
0
|
%
|
Volatility
|
|
|
260
|
%
|
Risk free rate:
|
|
|
0.11
|
%
|
The initial fair values of the
embedded debt derivative of $142,870 was allocated as a debt discount up to the proceeds of the note ($55,000) with the remainder
($87,870) charged to operations as derivative liability adjustment during the year ended December 31, 2014.
During the year ended December
31, 2014, the Company amortized $13,750 to current period operations as amortization of beneficial conversion feature.
During the year ended December
31, 2015, the Company amortized $41,250 to current period operations as amortization of beneficial conversion feature.
The fair value of the described
embedded derivative of $95,625 at December 31, 2015 was determined using the Black-Scholes Model with the following assumptions:
Dividend yield:
|
|
|
0
|
%
|
Volatility
|
|
|
279
|
%
|
Risk free rate:
|
|
|
0.16
|
%
|
At December 31, 2015, the Company
adjusted the recorded fair value of the derivative liability to market resulting in non-cash, non-operating loss of $10,134 for
the year ended December 31, 2015.
Note issued on November 12,
2014:
On November 12, 2014, the Company
entered into a twelve-month convertible debenture for $75,000 and a 5-year warrant to purchase an aggregate of 1,587,302 shares
with an accredited institutional investor. The debenture is convertible at 50% of the lowest trading price in the 20 trading days
prior to conversion. The warrant is exercisable at $0.24 per share subject to adjustments.
In accordance with ASC 470-20,
the Company recognized an embedded beneficial conversion feature in the notes. The Company allocated a portion of the proceeds
equal to the intrinsic value of that feature to additional paid-in capital. The Company recognized and measured an aggregate of
nil of the proceeds, which is equal to the intrinsic value of the embedded beneficial conversion feature. The Company identified
embedded derivatives related to the Convertible Promissory Notes entered into in November 2014. These embedded derivatives
included certain conversion features. The accounting treatment of derivative financial instruments requires that the Company
record the fair value of the derivatives as of the inception date of the Convertible Promissory Note and to adjust the fair value
as of each subsequent balance sheet date. At the inception of the Convertible Promissory Note, the Company determined a fair
value of $324,627 of the embedded derivative. The fair value of the embedded derivative was determined using the Black-Scholes
Model based on the following assumptions:
Dividend yield:
|
|
|
0
|
%
|
Volatility
|
|
|
261-275%
|
|
Risk free rate:
|
|
|
0.14
|
%
|
The initial fair values of the
embedded debt derivative of $324,627 was allocated as a debt discount up to the proceeds of the note ($75,000) with the remainder
($249,627) charged to operations as derivative liability adjustment during the year ended December 31, 2014.
During the year ended December
31, 2014, the Company amortized $4,795 to current period operations as amortization of beneficial conversion feature.
During the year ended December
31, 2015, the Company amortized $56,250 to current period operations as amortization of beneficial conversion feature.
The fair value of the described
embedded derivative of $101,204 at December 31, 2015 was determined using the Black-Scholes Model with the following assumptions:
Dividend yield:
|
|
|
0
|
%
|
Volatility
|
|
|
279
|
%
|
Risk free rate:
|
|
|
0.16
|
%
|
At December 31, 2015, the Company
adjusted the recorded fair value of the derivative liability to market resulting in non-cash, non-operating gain of $94,135 for
the year ended December 31, 2015.
Note issued on December 16,
2014:
On December 16, 2014, the Company
entered into a two-year convertible debenture for $39,772 with an accredited institutional investor. The debenture is convertible
at 60% of the lowest trading price in the 25 trading days prior to conversion.
The Company identified embedded
derivatives related to the Convertible Promissory Notes entered into in December 2014. These embedded derivatives included
certain conversion features. The accounting treatment of derivative financial instruments requires that the Company record
the fair value of the derivatives as of the inception date of the Convertible Promissory Note and to adjust the fair value as of
each subsequent balance sheet date. At the inception of the Convertible Promissory Note, the Company determined a fair value
of $85,288 of the embedded derivative. The fair value of the embedded derivative was determined using the Black-Scholes Model
based on the following assumptions:
Dividend yield:
|
|
|
0
|
%
|
Volatility
|
|
|
275
|
%
|
Risk free rate:
|
|
|
0.58
|
%
|
The initial fair values of the
embedded debt derivative of $85,288 was allocated as a debt discount up to the proceeds of the note ($39,722) with the remainder
($45,566) charged to operations as derivative liability adjustment during the year ended December 31, 2014.
During the year ended December
31, 2014, the Company amortized $1,655 to current period operations as amortization of beneficial conversion feature.
During the year ended December
31, 2015, the Company amortized $19,861 to current period operations as amortization of beneficial conversion feature.
The fair value of the described
embedded derivative of $84,713 at December 31, 2015 was determined using the Black-Scholes Model with the following assumptions:
Dividend yield:
|
|
|
0
|
%
|
Volatility
|
|
|
279
|
%
|
Risk free rate:
|
|
|
0.65
|
%
|
At December 31, 2015, the Company
adjusted the recorded fair value of the derivative liability to market resulting in non-cash, non-operating loss of $14,726 for
the year ended December 31, 2015.
Note issued on January 22,
2015:
On January 22, 2015, the Company
entered into a one-year convertible debenture for $75,000 with an accredited institutional investor. The debenture is convertible
at 55% of the lowest trading price in the 20 trading days prior to conversion.
The Company identified embedded
derivatives related to the Convertible Promissory Notes entered into in January 2015. These embedded derivatives included
certain conversion features. The accounting treatment of derivative financial instruments requires that the Company record
the fair value of the derivatives as of the inception date of the Convertible Promissory Note and to adjust the fair value as of
each subsequent balance sheet date. At the inception of the Convertible Promissory Note, the Company determined a fair value
of $210,982 of the embedded derivative. The fair value of the embedded derivative was determined using the Black-Scholes Model
based on the following assumptions:
Dividend yield:
|
|
|
0
|
%
|
Volatility
|
|
|
335
|
%
|
Risk free rate:
|
|
|
0.17
|
%
|
The initial fair values of the
embedded debt derivative of $210,982 was allocated as a debt discount up to the proceeds of the note ($75,000) with the remainder
($135,982) charged to operations as derivative liability adjustment during the year ended December 31, 2015.
During the year ended December
31, 2015, the Company amortized $75,000 to current period operations as amortization of beneficial conversion feature.
The fair value of the described
embedded derivative of $121,370 at December 31, 2015 was determined using the Black-Scholes Model with the following assumptions:
Dividend yield:
|
|
|
0
|
%
|
Volatility
|
|
|
279
|
%
|
Risk free rate:
|
|
|
0.16
|
%
|
At December 31, 2015, the Company
adjusted the recorded fair value of the derivative liability to market resulting in non-cash, non-operating gain of $89,611 for
the year ended December 31, 2015.
Note issued on January 29,
2015, converted to cash flow loan:
On January 29, 2015, the Company
entered into a nine-month convertible debenture for $28,000 with an accredited institutional investor. The debenture is convertible
at 58% of the average of the three lowest trading prices in the 10 trading days prior to conversion.
The Company identified embedded
derivatives related to the Convertible Promissory Notes entered into in January 2015. These embedded derivatives included
certain conversion features. The accounting treatment of derivative financial instruments requires that the Company record
the fair value of the derivatives as of the inception date of the Convertible Promissory Note and to adjust the fair value as of
each subsequent balance sheet date. At the inception of the Convertible Promissory Note, the Company determined a fair value
of $46,247 of the embedded derivative. The fair value of the embedded derivative was determined using the Black-Scholes Model
based on the following assumptions:
Dividend yield:
|
|
|
0
|
%
|
Volatility
|
|
|
336
|
%
|
Risk free rate:
|
|
|
0.11
|
%
|
The initial fair values of the embedded
debt derivative of $46,247 was allocated as a debt discount up to the proceeds of the note ($28,000) with the remainder ($18,247)
charged to operations as derivative liability adjustment during the year ended December 31, 2015.
During the year ended December 31,
2015, the Company amortized the $28,000 to the current period operations as amortization of beneficial conversion feature.
The fair value of the described
embedded derivative of $23,754 at September 30, 2015 was determined using the Black-Scholes Model with the following assumptions:
Dividend yield:
|
|
|
0
|
%
|
Volatility
|
|
|
280
|
%
|
Risk free rate:
|
|
|
0.0001
|
%
|
At September 30, 2015, the Company
adjusted the recorded fair value of the derivative liability to market resulting in non-cash, non-operating gain of $22,493 for
the nine months ended September 30, 2015.
On October 10, 2015, the Company
converted this loan into a cash flow loan with no conversion features. Accordingly, the Company recognized a gain on extinguishment
of debt in the amount of $28,904.
Note issued on February 9,
2015:
On February 9, 2015, the Company
entered into a one-year convertible debenture for $108,000 with an accredited institutional investor. The debenture is convertible
at 60% of the lowest trading price in the 20 trading days prior to conversion.
The Company identified embedded
derivatives related to the Convertible Promissory Notes entered into in February 2015. These embedded derivatives included
certain conversion features. The accounting treatment of derivative financial instruments requires that the Company record
the fair value of the derivatives as of the inception date of the Convertible Promissory Note and to adjust the fair value as of
each subsequent balance sheet date. At the inception of the Convertible Promissory Note, the Company determined a fair value
of $181,521 of the embedded derivative. The fair value of the embedded derivative was determined using the Black-Scholes Model
based on the following assumptions:
Dividend yield:
|
|
|
0
|
%
|
Volatility
|
|
|
336
|
%
|
Risk free rate:
|
|
|
0.11
|
%
|
The initial fair values of the
embedded debt derivative of $181,521 was allocated as a debt discount up to the proceeds of the note ($108,000) with the remainder
($73,521) charged to operations as derivative liability adjustment during the year ended December 31, 2015.
During the year ended December
31, 2015, the Company amortized $99,000 to current period operations as amortization of beneficial conversion feature.
The fair value of the described
embedded derivative of $139,323 at December 31, 2015 was determined using the Black-Scholes Model with the following assumptions:
Dividend yield:
|
|
|
0
|
%
|
Volatility
|
|
|
279
|
%
|
Risk free rate:
|
|
|
0.14
|
%
|
At December 31, 2015, the Company
adjusted the recorded fair value of the derivative liability to market resulting in non-cash, non-operating gain of $42,197 for
the year ended December 31, 2015.
Note issued on February 10,
2015:
On February 10, 2015, the Company
entered into a two-year convertible debenture for $22,000 with an accredited institutional investor. The debenture is convertible
at 60% of the lowest trading price in the 25 trading days prior to conversion.
The Company identified embedded
derivatives related to the Convertible Promissory Notes entered into in February 2015. These embedded derivatives included
certain conversion features. The accounting treatment of derivative financial instruments requires that the Company record
the fair value of the derivatives as of the inception date of the Convertible Promissory Note and to adjust the fair value as of
each subsequent balance sheet date. At the inception of the Convertible Promissory Note, the Company determined a fair value
of $41,170 of the embedded derivative. The fair value of the embedded derivative was determined using the Black-Scholes Model
based on the following assumptions:
Dividend yield:
|
|
|
0
|
%
|
Volatility
|
|
|
336
|
%
|
Risk free rate:
|
|
|
0.11
|
%
|
The initial fair values of the
embedded debt derivative of $41,170 was allocated as a debt discount up to the proceeds of the note ($22,000) with the remainder
($19,170) charged to operations as derivative liability adjustment during the year ended December 31, 2015.
During the year ended December
31, 2015, the Company amortized $22,000 to current period operations as amortization of beneficial conversion feature.
The fair value of the described
embedded derivative of $48,922 at December 31, 2015 was determined using the Black-Scholes Model with the following assumptions:
Dividend yield:
|
|
|
0
|
%
|
Volatility
|
|
|
279
|
%
|
Risk free rate:
|
|
|
0.65
|
%
|
At December 31, 2015, the Company
adjusted the recorded fair value of the derivative liability to market resulting in non-cash, non-operating loss of $7,751 for
the year ended December 31, 2015.
Note issued on February 19,
2015:
On February 19, 2015, the Company
entered into a one-year convertible debenture for $35,000 with an accredited institutional investor. The debenture is convertible
at 50% of the lowest trading price in the 20 trading days prior to conversion.
The Company identified embedded
derivatives related to the Convertible Promissory Notes entered into in February 2015. These embedded derivatives included
certain conversion features. The accounting treatment of derivative financial instruments requires that the Company record
the fair value of the derivatives as of the inception date of the Convertible Promissory Note and to adjust the fair value as of
each subsequent balance sheet date. At the inception of the Convertible Promissory Note, the Company determined a fair value
of $53,829 of the embedded derivative. The fair value of the embedded derivative was determined using the Black-Scholes Model
based on the following assumptions:
Dividend yield:
|
|
|
0
|
%
|
Volatility
|
|
|
336
|
%
|
Risk free rate:
|
|
|
0.11
|
%
|
The initial fair values of the
embedded debt derivative of $53,829 was allocated as a debt discount up to the proceeds of the note ($35,000) with the remainder
($18,829) charged to operations as derivative liability adjustment during the year ended December 31, 2015.
During the year ended December
31, 2015, the Company amortized $32,083 to current period operations as amortization of beneficial conversion feature.
The fair value of the described
embedded derivative of $58,999 at December 31, 2015 was determined using the Black-Scholes Model with the following assumptions:
Dividend yield:
|
|
|
0
|
%
|
Volatility
|
|
|
279
|
%
|
Risk free rate:
|
|
|
0.14
|
%
|
At December 31, 2015, the Company
adjusted the recorded fair value of the derivative liability to market resulting in non-cash, non-operating loss of $5,170 for
the year ended December 31, 2015.
Note issued on February 25,
2015:
On February 25, 2015, the Company
entered into a two-year convertible debenture for $33,333 with an accredited institutional investor. The debenture is convertible
at lower of $0.10 per share or 60% of the lowest trading price in the 25 trading days prior to conversion.
The Company identified embedded
derivatives related to the Convertible Promissory Notes entered into in February 2015. These embedded derivatives included
certain conversion features. The accounting treatment of derivative financial instruments requires that the Company record
the fair value of the derivatives as of the inception date of the Convertible Promissory Note and to adjust the fair value as of
each subsequent balance sheet date. At the inception of the Convertible Promissory Note, the Company determined a fair value
of $61,358 of the embedded derivative. The fair value of the embedded derivative was determined using the Black-Scholes Model
based on the following assumptions:
Dividend yield:
|
|
|
0
|
%
|
Volatility
|
|
|
340
|
%
|
Risk free rate:
|
|
|
0.10
|
%
|
The initial fair values of the
embedded debt derivative of $61,358 was allocated as a debt discount up to the proceeds of the note ($33,333) with the remainder
($28,025) charged to operations as derivative liability adjustment during the year ended December 31, 2015.
During the year ended December
31, 2015, the Company amortized $15,278 to current period operations as amortization of beneficial conversion feature.
The fair value of the described
embedded derivative of $74,476 at December 31, 2015 was determined using the Black-Scholes Model with the following assumptions:
Dividend yield:
|
|
|
0
|
%
|
Volatility
|
|
|
279
|
%
|
Risk free rate:
|
|
|
0.65
|
%
|
At December 31, 2015, the Company
adjusted the recorded fair value of the derivative liability to market resulting in non-cash, non-operating loss of $13,118 for
the year ended December 31, 2015.
Note issued on March 13, 2015:
On March 13, 2015, the Company
entered into an eight-month convertible debenture for $52,500 with an accredited institutional investor. The debenture is convertible
at 53% of the lowest trading price in the 20 trading days prior to the conversion.
The Company identified embedded
derivatives related to the Convertible Promissory Notes entered into in March 2015. These embedded derivatives included
certain conversion features. The accounting treatment of derivative financial instruments requires that the Company record
the fair value of the derivatives as of the inception date of the Convertible Promissory Note and to adjust the fair value as of
each subsequent balance sheet date. At the inception of the Convertible Promissory Note, the Company determined a fair value
of $73,432 of the embedded derivative. The fair value of the embedded derivative was determined using the Black-Scholes Model
based on the following assumptions:
Dividend yield:
|
|
|
0
|
%
|
Volatility
|
|
|
343
|
%
|
Risk free rate:
|
|
|
0.11
|
%
|
The initial fair values of the
embedded debt derivative of $73,432 was allocated as a debt discount up to the proceeds of the note ($52,500) with the remainder
($20,932) charged to operations as derivative liability adjustment during the year ended December 31, 2015.
During the year ended December
31, 2015, the Company amortized $52,500 to current period operations as amortization of beneficial conversion feature.
The fair value of the described
embedded derivative of $86,004 at December 31, 2015 was determined using the Black-Scholes Model with the following assumptions:
Dividend yield:
|
|
|
0
|
%
|
Volatility
|
|
|
297
|
%
|
Risk free rate:
|
|
|
0.16
|
%
|
At December 31, 2015, the Company
adjusted the recorded fair value of the derivative liability to market resulting in non-cash, non-operating loss of $12,572 for
the year ended December 31, 2015.
|
7.
|
Fair Value of Financial Instruments
|
ASC 825-10 defines fair value as
the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market
participants at the measurement date. When determining the fair value measurements for assets and liabilities required or permitted
to be recorded at fair value, the Company considers the principal or most advantageous market in which it would transact and considers
assumptions that market participants would use when pricing the asset or liability, such as inherent risk, transfer restrictions,
and risk of nonperformance. ASC 825-10 establishes a fair value hierarchy that requires an entity to maximize the use of observable
inputs and minimize the use of unobservable inputs when measuring fair value. ASC 825-10 establishes three levels of inputs that
may be used to measure fair value:
Level 1 - Quoted prices in active markets for identical
assets or liabilities.
Level 2 - Observable inputs other
than Level 1 prices such as quoted prices for similar assets or liabilities; quoted prices in markets with insufficient volume
or infrequent transactions (less active markets); or model-derived valuations in which all significant inputs are observable or
can be derived principally from or corroborated by observable market data for substantially the full term of the assets or liabilities.
Level 3 - Unobservable inputs to
the valuation methodology that are significant to the measurement of fair value of assets or liabilities.
To the extent that valuation is
based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more
judgment. In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In
such cases, for disclosure purposes, the level in the fair value hierarchy within which the fair value measurement is disclosed
is determined based on the lowest level input that is significant to the fair value measurement.
Items recorded or measured at fair
value on a recurring basis in the accompanying unaudited condensed consolidated financial statements consisted of the following
items as of December 31, 2015:
|
|
|
|
Fair Value Measurements at
December 31, 2015 using:
|
|
|
December 31,
2015
|
|
Quoted Prices in Active
Markets for
Identical
Assets
(Level 1)
|
|
Significant
Other
Observable
Inputs
(Level 2)
|
|
Significant
Unobservable Inputs
(Level 3)
|
Liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Derivative Liabilities
|
|
$
|
1,046,635
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
1,046,635
|
The debt and warrant derivative liabilities
is measured at fair value using quoted market prices and estimated volatility factors based on historical prices for the Company’s
common stock and are classified within Level 3 of the valuation hierarchy.
The following table provides a summary
of changes in fair value of the Company’s Level 3 financial liabilities as of December 31, 2015:
|
|
Derivative
Liability
|
Balance, December 31, 2014
|
|
$
|
1,018,782
|
Additions
|
|
|
668,539
|
Change in fair value of derivative liabilities
|
|
|
(640,686)
|
Balance, December 31, 2015
|
|
$
|
1,046,635
|
During the year ended December
31, 2013, the Company entered into various agreements for future services such as financial management, radio and news spots
highlighting the use of the Company’s product, and news release services. The contracts range in length from six months
to two years.
At their inception, the Company
issued common stock in exchange for these services. The Company treats the cost of the stock issuance as a prepaid expense
to be amortized over the life of the agreement.
Balance at
December 31, 2014
|
|
Amortized in 2015
|
|
Balance at
December 31, 2015
|
|
Current Asset
|
|
Long Term Asset
|
$
|
260,000
|
|
|
$
|
253,000
|
|
|
$
|
7,000
|
|
|
$
|
7,000
|
|
|
$
|
0
|
|
9.
|
Related Party Transactions
|
In November 2014, our President
transferred some of his personal stock in payment of a retainer to one of our legal firms. The stock was liquidated by the firm
and they applied $22,967 to the ongoing legal expense. The balance of the account payable is carried in our accounts payable as
a liability and is due to our President.
As of December 31, 2015, and 2014,
the Company owes $26,456 and $3,489, respectively to its President. The amounts owing are unsecured, non-interest bearing,
and due on demand.
As of December 31, 2015, and 2014,
the Company owes its president $240,000 and $120,000, respectively, of accrued compensation.
As of December 31, 2015, and 2014,
the Company owes $214,000 and $120,000, respectively to Kaufman & Associates in connection with a consulting agreement.
On December 9, 2015, the Company
issued 2,000,000 Series D Convertible Preferred shares each as compensation to its CEO and Kaufman & Associates a consultant.
|
10.
|
Stockholders’ Deficit
|
Where applicable, all common share
numbers have been restated to retroactively reflect, the 1:3 reverse split affected by the Company on January 8, 2014.
a)
Authorized
Authorized capital stock consists of:
·
900,000,000
common shares with a par value of $0.001 per share; and
· 10
0,000,000
preferred shares with a par value of $0.001 per share;
|
o
|
The Company has designated 12,000,000 shares as Series A Convertible
Preferred Series Stock. Each share of Series A Preferred Stock is convertible into five (5) share of Common Stock.
|
|
o
|
The Company has designated 70,000,000 shares as Series B Convertible
Preferred Series Stock. Each share of Series B Preferred Stock is convertible into one (1) share of Common Stock.
|
|
o
|
The Company has designated 10,000,000 shares as Series C Convertible
Preferred Series Stock. Each share of Series C Preferred Stock is convertible into $1.00 of Common Shares at the market price on
the date of conversion.
|
|
o
|
The Company has designated 4,000,000 shares as Series D Convertible
Preferred Series Stock. Each share of Series D Preferred Stock is convertible into ten (10) shares of Common Stock. See additional
description and preferences under “Series D Preferred Stock” below.
|
Increase in authorized shares
On January 24, 2014, the Company
filed a Certificate of Amendment to the Company’s Articles of Incorporation (the “Certificate of Amendment”)
with the Nevada Secretary of State. The Certificate of Amendment amends Article III of the Company’s Articles of Incorporation
to authorize the issuance of up to one hundred million (100,000,000) shares of Preferred Stock, par value $0.001 per share, which
may be issued in one or more series, with such rights, preferences, privileges and restrictions as shall be fixed by the Company’s
Board of Directors from time to time. As a result of the Certificate of Amendment, we now have one billion (1,000,000,000) authorized
shares, par value $0.001 per share, consisting of two classes designated as “Common Stock” and “Preferred Stock.”
The total number of shares of Common Stock that we have authority to issue is nine hundred million (900,000,000) shares and the
total number of shares of Preferred Stock that we have authority to issue is one hundred million (100,000,000) shares. The Company’s
Board of Directors and a majority of our shareholders approved the Certificate of Amendment.
In May 2016, we again increased
the authorized shares of Common Stock of our company from 900,000,000 to 5,500,000,000.
As of the date of this filing, the Company
has issued all authorized common shares, and as such, can no longer issue such shares until such time as the Company has received
approval from our shareholders, and have filed an increase in the authorized common shares with the State of Nevada.
Series A Preferred Stock:
This series of Preferred Stock shall
be designated and known as “Series A Preferred Stock.” The number of shares constituting the Series A Preferred Stock
shall be twelve million (12,000,000) shares. Except as otherwise provided herein, the Series A Preferred Stock shall, with respect
to rights on liquidation, winding up and dissolution, rank
pari passu
to the common stock, par value $0.001 per share (the
“Common Stock”).
2. Dividends.
The holders of shares of Series
A Preferred Stock have no dividend rights except as may be declared by the Board in its sole and absolute discretion, out of funds
legally available for that purpose.
3. Liquidation Preference.
(a) In the event of any dissolution,
liquidation or winding up of the Corporation (a “Liquidation”), whether voluntary or involuntary, the Holders of Series
A Preferred Stock shall be entitled to participate in any distribution out of the assets of the Corporation on an equal basis per
share with the holders of the Common Stock.
(b) A sale of all or substantially
all of the Corporation’s assets or an acquisition of the Corporation by another entity by means of any transaction or series
of related transactions (including, without limitation, a reorganization, consolidated or merger) that results in the transfer
of fifty percent (50%) or more of the outstanding voting power of the Corporation (a “Change in Control Event”), shall
not be deemed to be a Liquidation for purposes of this Designation.
4. Voting.
The holders of Series A Preferred
Stock shall have the right to cast one hundred (100) votes for each share held of record on all matters submitted to a vote of
holders of the Corporation’s common stock, including the election of directors, and all other matters as required by law.
There is no right to cumulative voting in the election of directors. The holders of Series A Preferred Stock shall vote together
with all other classes and series of common stock of the Corporation as a single class on all actions to be taken by the common
stock holders of the Corporation except to the extent that voting as a separate class or series is required by law.
On October 7, 2013, the Company
filed an Amendment to the Certificate of Designation of the Series A Preferred Stock of the Company with the Secretary of State
of Nevada. Paragraph 1 of the Certificate of Designation was amended to change the name of the Series A Preferred Stock to Series
A Convertible Preferred Stock and to increase the number of authorized Series A Convertible Preferred Stock from 10,000,000 shares
to 12,000,000 shares. The Company also added a new Paragraph 5 to include conversion rights of the Series A Convertible Preferred
Stock. Each share of Series A Convertible Preferred Stock may convert into fifty (50) shares of common stock of the Company.
Series B Convertible Preferred Stock
On January 24, 2014, pursuant to
Article III of our Articles of Incorporation, the Company’s Board of Directors voted to designate a class of preferred stock
entitled Series B Preferred Stock, consisting of up to seventy million (70,000,000) shares, par value $0.001. Under the Certificate
of Designation, holders of Series B Preferred Stock will participate on an equal basis per-share with holders of our common stock
and Series A Preferred Stock in any distribution upon winding up, dissolution, or liquidation. Holders of Series B Preferred Stock
are entitled to convert each share of Series B Preferred Stock into one (1) share of common stock. Holders of Series B Preferred
Stock are also entitled to vote together with the holders of our common stock and Series A Preferred Stock on all matters submitted
to shareholders at a rate of one (1) vote for each share held.
The rights of the holders of Series
B Preferred Stock are defined in the relevant Certificate of Designation filed with the Nevada Secretary of State on January 24,
2014.
Series C Convertible Preferred Stock
On January 24, 2014, pursuant to
Article III of our Articles of Incorporation, the Company’s Board of Directors voted to designate a class of preferred stock
entitled Series C Preferred Stock, consisting of up to ten million (10,000,000) shares, par value $0.001. Under the Certificate
of Designation, holders of Series C Preferred Stock will be entitled to receive the Stated Value per share ($1.00) in any distribution
upon winding up, dissolution, or liquidation. Holders of Series C Preferred Stock are entitled to convert such number of shares
of Common Stock equal to the quotient of the Stated Value per share divided by the closing price of our common stock on the day
of conversion. Holders of Series C Preferred Stock are also entitled to vote together with the holders of our common stock, Series
A Preferred Stock and Series B Preferred Stock on all matters submitted to shareholders at a rate of one (1) vote for each share
held.
The rights of the holders of Series
C Preferred Stock are defined in the relevant Certificate of Designation filed with the Nevada Secretary of State on January 24,
2014.
Series D Convertible Preferred Stock
On December 2, 2015, pursuant to
Article III of our Articles of Incorporation, the Company’s Board of Directors voted to designate a class of preferred stock
entitled Series D Preferred Stock, consisting of up to four million (4,000,000) shares, par value $0.001. Under the Certificate
of Designation, holders of Series D Preferred Stock will be entitled to receive the value at which they were issued ($0.003 per
share) in any distribution upon winding up, dissolution, or liquidation. Holders of Series D Preferred Stock are entitled to convert
such number of shares to Common Stock equal to the number of Series D Preferred Stock held multiplied by ten (10). Holders of Series
D Preferred Stock are also entitled to vote together with the holders of our common stock, Series A Preferred Stock and Series
B Preferred Stock on all matters submitted to shareholders at a rate of twenty-five thousand (25,000) votes for each share held.
The rights of the holders of Series
D Preferred Stock are defined in the relevant Certificate of Designation filed with the Nevada Secretary of State on December 2,
2015.
b)
Share Issuances
As of December 31, 2015, and 2014,
there were 198,485,547 and 74,045,606 shares of common stock issued and outstanding, respectively.
2015:
On January 12, 2015, the Company
issued 3,600,000 common shares upon conversion of $69,336 of accounts payable in connection with a settlement under the Section
3(a)10 of the Rules of the SEC. The shares were issued at a price of $0.01926 per share.
On February 4, 2015, the Company
issued 3,000,000 common shares upon conversion of $54,000 of accounts payable in connection with a settlement under the Section
3(a)10 of the Rules of the SEC. The shares were issued at a price of $0.018 per share.
On February 9, 2015, the Company
issued 2,000,000 common shares upon conversion of $36,210 of convertible debt. The shares were issued at a price of $0.01806 per
share.
On February 17, 2015, the Company
issued 1,428,571 common shares upon conversion of $25,000 of convertible debt. The shares were issued at a price of $0.0175 per
share.
On February 20, 2015, the Company
issued 3,500,000 common shares upon conversion of $56,910 of accounts payable in connection with a settlement under the Section
3(a)10 of the Rules of the SEC. The shares were issued at a price of $0.01626 per share.
On February 23, 2015, the Company
issued 1,481,481 common shares upon conversion of $20,000 of convertible debt. The shares were issued at a price of $0.0135 per
share.
On February 24, 2015, the Company
issued 1,750,000 common shares upon conversion of $17,850 of convertible debt. The shares were issued at a price of $0.0102 per
share.
On February 25, 2015, the Company
issued 2,500,000 common shares upon conversion of $32,500 of convertible debt. The shares were issued at a price of $0.013 per
share.
On February 25, 2015, the Company
issued 2,686,667 common shares upon conversion of $22,837 of convertible debt and accrued interest. The shares were issued at a
price of $0.0085 per share.
On February 26, 2015, the Company
issued 1,518,333 common shares upon conversion of $18,220 of convertible debt and accrued interest. The shares were issued at a
price of $0.012 per share.
On March 5, 2015, the Company issued
1,800,000 common shares upon conversion of $13,500 of convertible debt. The shares were issued at a price of $0.0075 per share.
On March 10, 2015, the Company issued
4,500,000 common shares upon conversion of $31,860 of accounts payable in connection with a settlement under the Section 3(a)10
of the Rules of the SEC. The shares were issued at a price of $0.00708 per share.
On March 12, 2015, the Company issued
3,424,658 common shares upon conversion of $25,000 of convertible debt. The shares were issued at a price of $0.0073 per share.
On March 12, 2015, the Company issued
3,653,013 common shares upon conversion of $25,863 of convertible debt. The shares were issued at a price of $0.00708 per share.
On March 12, 2015, the Company issued
4,955,500 common shares upon conversion of $33,797 of convertible debt and accrued interest. The shares were issued at a price
of $0.00682 per share.
On March 12, 2015, the Company issued
1,736,111 common shares upon conversion of $12,500 of convertible debt. The shares were issued at a price of $0.0072 per share.
On March 16, 2015, the Company issued
1,000,000 common shares upon conversion of $6,700 of convertible debt and accrued interest. The shares were issued at a price of
$0.0067 per share.
On March 18, 2015, the Company issued
5,000,000 common shares upon conversion of $21,600 of accounts payable in connection with a settlement under the Section 3(a)10
of the Rules of the SEC. The shares were issued at a price of $0.00432 per share.
On March 26, 2015, the Company issued
5,697,909 common shares upon conversion of $19,886 of convertible debt and accrued interest. The shares were issued at a price
of $0.00349 per share.
On March 30, 2015, the Company issued
2,106,545 common shares upon conversion of $4,880 of convertible debt and accrued interest. The shares were issued at a price of
$0.00231 per share.
On March 31, 2015, the Company issued
6,600,000 common shares upon conversion of $15,048 of accounts payable in connection with a settlement under the Section 3(a)10
of the Rules of the SEC. The shares were issued at a price of $0.00228 per share.
On April 15, 2015, the Company issued
6,000,000 common shares upon conversion of $14,400 of accounts payable in connection with a settlement under the Section 3(a)10
of the Rules of the SEC. The shares were issued at a price of $0.0024 per share.
On May 4, 2015, the Company issued
7,400,000 common shares upon conversion of $29,748 of accounts payable in connection with a settlement under the Section 3(a)10
of the Rules of the SEC. The shares were issued at a price of $0.00402 per share.
On June 2, 2015, the Company issued
5,118,865 common shares upon conversion of $30,713 of accounts payable in connection with a settlement under the Section 3(a)10
of the Rules of the SEC. The shares were issued at a price of $0.006 per share.
On June 17, 2015, the Company issued
5,000,000 common shares upon conversion of $39,900 of accounts payable in connection with a settlement under the Section 3(a)10
of the Rules of the SEC. The shares were issued at a price of $0.00798 per share.
On August 5, 2015, the Company issued
8,000,000 common shares upon conversion of $26,880 of accounts payable in connection with a settlement under the Section 3(a)10
of the Rules of the SEC. The shares were issued at a price of $0.00336 per share.
On August 25, 2015, the Company
issued 7,000,000 common shares upon conversion of $21,000 of accounts payable in connection with a settlement under the Section
3(a)10 of the Rules of the SEC. The shares were issued at a price of $0.003 per share.
On September 28, 2015, the Company
issued 5,482,288 common shares upon conversion of $10,855 of accounts payable in connection with a settlement under the Section
3(a)10 of the Rules of the SEC. The shares were issued at a price of $0.00198 per share.
On September 30, 2015 the Company
recorded additional $24,718 as value of shares sold in payment of debt in excess of value in connection with the August and September
2015 settlements under the Section 3(a)10 of the Rules of the SEC.
On November 12, 2015, the Company
issued 9,000,000 common shares upon conversion of $17,280 of accounts payable in connection with a settlement under the Section
3(a)10 of the Rules of the SEC. The shares were issued at a price of $0.00192 per share.
On December 9, 2015, the Company
issued 2,000,000 Series D Convertible Preferred shares as compensation to its CEO and a consultant. The shares were issued at a
price of $0.003 per common share into which they are convertible.
On December 29, 2015, the Company
issued 7,500,000 common shares upon conversion of $18,000 of accounts payable in connection with a settlement under the Section
3(a)10 of the Rules of the SEC. The shares were issued at a price of $0.0024 per share.
On December 31, 2015 the Company
recorded additional $21,056 as value of shares sold in payment of debt in excess of value in connection with the November and December
2015 settlements under the Section 3(a)10 of the Rules of the SEC.
2014:
On January 28, 2014, six stockholders
exchanged a total of 65,210,834 common shares for 65,210,834 Series B Convertible Preferred Stock.
On March 3, 2014, the Company issued
187,500 shares of Series B Convertible Preferred Stock to a distributor in payment of a one-year fee agreement. The shares were
issued at a price of $0.48 per share.
On September 15, 2014, the Company
issued 4,166,667 common shares at a price of $0.15 per share to an accredited investor as a commitment fee connected with the application
for a $5.0 million equity line of credit.
On October 27, 2014, the Company
recorded stock to be issued of 100,000 common shares in connection with the closing of the High-Country Shrimp acquisition. The
pending shares were recorded at a price of $0.135 per share.
c) Warrants
The following table summarizes the changes
in warrants outstanding and related prices for the shares of the Company’s common stock issued to shareholders at December
31, 2015:
Exercise
Price
|
|
Number
Outstanding
|
|
Warrants
Outstanding
Weighted Average
Remaining
Contractual
Life (years)
|
|
Weighted
Average
Exercise price
|
|
Number
Exercisable
|
|
Warrants
Exercisable
Weighted
Average
Exercise Price
|
$
|
|
|
|
0.24
|
|
|
|
1,587,302
|
|
|
|
3.87
|
|
|
$
|
0.24
|
|
|
|
1,587,302
|
|
|
$
|
0.24
|
Transactions involving the Company’s warrant issuance are
summarized as follows:
|
|
Number of
Shares
|
|
Weighted
Average
Price Per Share
|
Outstanding at December 31, 2013
|
|
|
|
—
|
|
|
$
|
—
|
Issued
|
|
|
|
1,587,302
|
|
|
|
0.24
|
Exercised
|
|
|
|
—
|
|
|
|
—
|
Expired
|
|
|
|
—
|
|
|
|
—
|
Outstanding at December 31, 2014
|
|
|
|
1,587,302
|
|
|
$
|
0.24
|
Issued
|
|
|
|
—
|
|
|
|
—
|
Exercised
|
|
|
|
—
|
|
|
|
—
|
Expired
|
|
|
|
—
|
|
|
|
—
|
Outstanding at December 31, 2015
|
|
|
|
1,587,302
|
|
|
$
|
0.24
|
Warrants outstanding as of December 31, 2015, as disclosed in the
above table, have an intrinsic value of $0.
Deferred income tax assets as of
December 31, 2015 of $3,282,104 resulting from net operating losses and future amortization deductions, have been fully offset
by valuation allowances. The valuation allowances have been established equal to the full amounts of the deferred tax assets,
as the Company is not assured that it is more likely than not that these benefits will be realized.
Reconciliation between the statutory
United States corporate income tax rate (34%) and the effective income tax rates based on continuing operations is as follows:
Year ended December 31,
|
|
2015
|
|
2014
|
Income tax benefit at Federal statutory rate of 34%
|
|
$
|
(608,600
|
)
|
|
$
|
(567,800)
|
State Income tax benefit, net of Federal effect
|
|
|
(89,500
|
)
|
|
|
(83,500)
|
Permanent and other differences
|
|
|
1,058,003
|
|
|
|
(652,387)
|
|
|
|
|
|
|
|
|
Change in valuation allowance
|
|
|
(359,903
|
)
|
|
|
(1,303,687)
|
Total
|
|
$
|
—
|
|
|
$
|
—
|
Components of deferred tax assets
were approximately as follows:
As at December 31,
|
|
2015
|
|
2014
|
Net operating loss
|
|
$
|
3,382,724
|
|
|
$
|
2,684,624
|
Asset impairment
|
|
|
—
|
|
|
|
—
|
Reserves and other deferred tax attributes
|
|
|
(100,620
|
)
|
|
|
(8,970)
|
Valuation allowance
|
|
|
(3,282,104
|
)
|
|
|
(2,675,654)
|
Total
|
|
$
|
—
|
|
|
$
|
—
|
At December 31, 2015, the Company
has available net operating losses of approximately $8,695,000 which may be carried forward to apply against future taxable income.
These losses will expire in 2035. Deferred tax assets related to these losses have not been recorded due to uncertainty regarding
their utilization.
The provisions of ASC 740 require
companies to recognize in their financial statements the impact of a tax position if that position is more likely than not to be
sustained upon audit, based upon the technical merits of the position. ASC 740 prescribes a recognition threshold and measurement
attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken on a tax return.
ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim periods and disclosure.
Management does not believe that
the Company has any material uncertain tax positions requiring recognition or measurement in accordance with the provisions of
ASC 740. Accordingly, the adoption of these provisions of ASC 740 did not have a material effect on the Company’s financial
statements. The Company’s policy is to record interest and penalties on uncertain tax positions, if any, as income tax expense.
The Company has not filed its applicable
Federal and State tax returns for the year ended December 31, 2012, 2013, and 2014 and may be subject to penalties for noncompliance.
The Company has filed an extension for the 2015 filing.
As a result of stock issuances in
2013 and 2015, the future utilization of the Company’s net operating losses is likely limited pursuant to Internal Revenue
Code section 382. The deferred tax asset derived from these tax loss carry-forwards have been included in consolidated deferred
tax assets - net operating loss carry-forwards, and a full valuation allowance has been established since it is not more likely
than not that such benefits will be recovered.
Inventory
Inventories are stated at cost,
with cost being determined on the average cost method. Inventory costs include material, import control costs, unpacking at the
warehouse facility, and freight charges. The Company provides inventory allowances based on excess and obsolete inventories determined
primarily by future demand forecasts.
Inventory in Transit
Inventory in transit is stated at
actual cost invoiced by the supplier at time of shipment.
Cost of Sales
At the time of sale, the Cost of
Sales is computed at actual cost based on first-in, first-out accounting.
Inventory consisted of:
|
|
December 31, 2015
|
|
December 31, 2014
|
Inventory – Raw Materials
|
|
$
|
30,886
|
|
|
$
|
53,806
|
Inventory – Finished Goods
|
|
|
29,018
|
|
|
|
16,437
|
Total
|
|
$
|
59,904
|
|
|
$
|
70,243
|
At December 31, 2015, the Company wrote off all remaining
inventory of its Xtreme subsidiary.
|
13.
|
Commitments and Contingencies
|
Litigation
a) In April 2014, the Company was
notified that a note holder disputes the balance of his note as recorded on the books of the Company. The discrepancy arises
from a question regarding expenses that the holder claims were paid on behalf of the Company and subsequent payments that the Company
recorded as payments against the note. The Company has no record of the expenses claimed to be due, and is in negotiations
to settle this matter. The Company has accrued $28,000 to cover the potential expenses and adjustments to accrued interest
if the claim is substantiated. The Company believes it has properly accounted for all payments made to the individual and
has provided documentation to him substantiating its position.
b)
In May 2014, the Company received notice that a complaint was filed in District Court, Clark County, NV alleging that the
Company and various unnamed defendants are liable to a Mr. Renard Wiggins with regard to commissions and equity purportedly
owed Mr. Wiggins, for services allegedly rendered in raising capital on behalf of the Company prior to the reverse merger
between Alkame Holdings, Inc. (fka Pinacle Enterprises Inc.) and Alkame Water, Inc. in June 2013. After initial review, the
Company has filed for a dismissal of the case with the District Court, does not believe there is any validity to the claims
of Mr. Wiggins, and intends to vigorously continue defending against these claims. As of December 31, 2015, all but two
claims have been dismissed, and the Company is in court mandated settlement talks to determine if the remaining counts can be
dismissed or will require further litigation. On November 15, 2016, the Company entered into a stipulated settlement agreement to
issue 200,000,000 common shares in full and final settlement of this matter and all legal complaints are withdrawn.
In
June 2018, the Company issued 92,780,388 shares of the agreed upon settlement.
The Company may, from time to time,
become involved in various lawsuits and legal proceedings, which arise in the ordinary course of business. However, litigation
is subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that may harm
our business. The Company is currently not aware of any such legal proceedings that it believes will have, individually or in the
aggregate, a material adverse effect on its business, financial condition or operating results.
Material Agreements
Stock Purchase Definitive Agreement
with Xtreme Technologies, Inc.
On April 21, 2014, we entered into a Stock
Purchase Definitive Agreement (the “Agreement”) with Xtreme Technologies, Inc., an Idaho corporation (“Xtreme”).
Pursuant to the terms of the Agreement, we agreed to acquire all of the issued and outstanding capital stock of Xtreme in exchange
for certain consideration as set forth in the Agreement.
On January 16, 2015, the parties to the Agreement
entered into an amendment (the “Amendment”) that changed, among other things, the Closing Date of the transaction.
On April 15, 2015, the parties to the Agreement
entered into a second amendment (the “Second Amendment”) that changed, among other things, the 120-day time period
to pay monetary consideration under the Agreement to 240 days after the Closing Date of the transaction.
In accordance with the terms of the Agreement,
the Amendment and the Second Amendment, we agreed to purchase all of the outstanding shares of Xtreme for the purchase price of
$2,000,000, payable as follows:
-
A cash payment of $50,000 has been previously paid as a non-refundable
deposit;
-
The Closing Date is effective as of January 13, 2015;
-
An additional cash payment of $525,000 shall be paid within two hundred
and forty (240) days of the Closing Date, which, along with the initial $50,000 deposit, shall pay the obligations on Xtreme’s
balance sheet;
-
The balance of $1,425,000 shall be payable by the issuance of shares
of the Company’s Series B Preferred Stock to be divided
pro rata
among the Company’s shareholders of record
as of the Closing Date. The Series B Preferred Stock shall include an option to convert each share of Series B Preferred Stock
into one share of the Company’s Common Stock. The Series B Preferred Stock shall be held in escrow along with the issued
and outstanding shares of Xtreme’s capital stock pending the full payment of $525,000. As of the date of this report, the
balance of $525,000 has been fully paid to Xtreme; and
-
One of Xtreme’s previous officers and directors holds outstanding
options to purchase up to 1,009,000 shares of Xtreme’s common stock at the price of $0.10 per share. At the Closing Date,
pursuant to Idaho law, Xtreme shall notify this previous officer and director of his 30-day right to exercise any or all of his
remaining options. If he elects to exercise any of his options within such 30-day period, the Company agrees to issue additional
shares of Series B Preferred Stock in exchange for such Xtreme shares. Xtreme notified the option holder and the 30-day period
expired unanswered. The options expired unexercised.
The Amendment also requires that the Company
guarantee the obligations on employment agreements for Xtreme’s key employees, namely, Keith Fuqua, Timm Ott and Casey Henry.
The employment agreements with Messrs. Fuqua, Ott and Henry have the terms set forth in the following table.
Employee
|
Position
|
Term
|
Compensation
|
Commission
|
Benefits
|
Severance
|
Keith Fuqua
|
Operations Director
|
One year
|
$70,000 annually and annual bonus
|
5% on gross sales made to Walmart
|
Benefit plans
|
6 months’ severance for termination in certain instances; residual commissions for 1 year
|
Timm Ott
|
Sales and Marketing Director and Treasurer
|
One year
|
$2,700 per month salary and annual bonus
|
$1.00 per case of product sold
|
Benefit plans
|
6 months’ severance for termination in certain instances
|
Casey Henry
|
Manufacturing Director
|
One year
|
$4,350 per month and annual bonus
|
$1.00 per case of product sold
|
Benefit plans
|
6 months’ severance for termination in certain instances
|
In addition, after the Closing Date, Xtreme’s
current officers and directors, namely, Jeffery J. Crandall, John N. Marcheso and Michael J. Bibin, shall continue to serve in
that capacity until the $525,000 is paid in full. Our President and CEO, Robert K. Eakle and two (2) additional representatives
of our company shall be appointed as directors of Xtreme and shall serve together with the other directors until the $525,000 is
paid in full. In addition, Mr. Eakle shall be named as President and Chief Executive Officer of Xtreme. Until the $525,000 is paid
in full, the officers and directors of Xtreme shall not make any material change in the company’s business and operations
without unanimous consent of the directors. If the $525,000 is not paid in full within two hundred and forty (240) days of the
Closing Date, as may be extended, then the appointments of Mr. Eakle and the other two representatives as interim officers and
directors shall be terminated. Upon payment of $525,000 in full to Xtreme, all former officers and directors of Xtreme shall resign
and full control of Xtreme shall be tendered to us. Provided that certain representations are accurate, Jeffery J. Crandall, John
N. Marcheso and Michael J. Bibin shall be released by us and Xtreme from any liability as officers and directors of Xtreme for
their fiduciary obligations occurring prior to the Closing Date.
We previously held a three-year limited exclusive
distribution agreement with Xtreme for the consumer market. We were permitted to distribute the technologically enhanced bottled
water in the consumer market in the United States, Canada and Mexico. As a result of the Agreement, Amendment, and Second Amendment,
Xtreme became our wholly-owned subsidiary and we acquired the patents on the proprietary process that we believe is the most technologically
advanced in water treatment systems for complete hydration. We will now assume the operations of Xtreme and continue its business
of distributing technologically enhanced bottled water.
Upon closing of the acquisition, we discovered
that Xtreme was operating at a loss for the prior year and that it required a substantial cash infusion. We have begun a program
of upgrading the production line, reorganized personnel, and began an effort to increase sales of the division so that it returns
to profitability as quickly as possible.
Our primary objective
now is to introduce, promote, aggressively market and establish channels of distribution to sell our product to a wide range of
consumers, first in the United States, Canada and Mexico, and then globally.
We believe that holding the patents will enable
us to enhance our position in the investment community, allow us to expand our reach in the distribution of product, and provide
us access to other applications the water treatment technology has available.
Employment Agreement with Robert
Eakle
On December 31, 2014, we entered
into a three-year employment agreement with our executive officer and director, Robert Eakle, retroactive for the year ended 2014
(the “2014 Employment Agreement”).
Pursuant to the terms and conditions
of the 2014 Employment Agreement with Mr. Eakle:
|
·
|
For the fiscal year ended December 31, 2014, we agreed to retain Mr. Eakle as Chief Executive Officer
of our company and Mr. Eakle agreed to accept this senior officer position.
|
|
·
|
The term will encompass the fiscal year ended 2014.
|
|
·
|
Mr. Eakle shall receive an annual compensation of $120,000.
|
|
·
|
In the event of insufficient liquidity, Mr. Eakle will be allowed to receive any unpaid and accrued
portion of his cash compensation in the form of common stock or Series B Preferred Stock, as he may choose.
|
Consulting Agreement with Kaufman
& Associates Inc.
On December 31, 2014, we entered
into a three-year consulting agreement with Kaufman & Associates Inc. (“Kaufman”) retroactive for the year ended
2014 (the “2014 Consulting Agreement”).
Pursuant to the terms and conditions
of the 2014 Consulting Agreement with Kaufman:
|
·
|
For the fiscal year ended December 31, 2014, we agreed to retain Kaufman as a consultant and Kaufman
agreed to act as a consultant.
|
|
·
|
The term will encompass the fiscal year ended 2014.
|
|
·
|
Kaufman shall receive an annual compensation of $120,000.
|
|
·
|
In the event of insufficient liquidity, Kaufman will be allowed to receive any unpaid and accrued
portion of his cash compensation in the form of common stock or Series B Preferred Stock, as it may choose.
|
On November 25, 2015,
we entered into an employment agreement with our executive officer and director, Robert Eakle, retroactive for the year ended 2015
(the “2015 Employment Agreement”).
Pursuant to the terms
and conditions of the 2015 Employment Agreement with Mr. Eakle:
·
For the fiscal year ended December 31, 2015, we agreed to retain Mr. Eakle as Chief Executive
Officer of our company and Mr. Eakle agreed to accept this senior officer position.
·
The term will encompass the fiscal year ended 2015.
·
Mr. Eakle shall receive an annual compensation of $120,000.
·
Mr. Eakle will received 1,000,000 shares of our newly created Series D Preferred Stock.
·
In the event of insufficient liquidity, Mr. Eakle will be allowed to receive any unpaid and
accrued portion of his cash compensation in the form of common stock or Series D Preferred Stock, as he may choose.
On December 31, 2015,
we entered into a consulting agreement with Kaufman & Associates Inc. (“Kaufman”) retroactive for the year ended
2015 (the “2015 Consulting Agreement”).
|
·
|
Pursuant to the terms and conditions of the 2015 Consulting Agreement
with Kaufman:
|
|
·
|
For the fiscal year ended December 31, 2015, we agreed to retain
Kaufman as a consultant and Kaufman agreed to act as a consultant.
|
|
·
|
The term will encompass the fiscal year ended 2015.
|
|
·
|
Kaufman shall receive an annual compensation of $120,000.
|
|
·
|
Kaufman will receive 1,000,000 shares of our newly created Series
D Preferred Stock.
|
|
·
|
In the event of insufficient liquidity, Kaufman will be allowed to
receive any unpaid and accrued portion of his cash compensation in the form of common stock or Series D Preferred Stock, as it
may choose.
|
The foregoing description
of the 2015 Employment Agreement and 2015 Consulting Agreement does not purport to be complete and is qualified in its entirety
by reference to the complete text of the agreements filed as Exhibits 10.1 and 10.2 to an 8K filed November 30, 2015 and incorporated
herein by reference
High County Shrimp
On October 26, 2014, we acquired all 100% of
the outstanding shares of High Country Shrimp Company (“HCS”), a Colorado LLC in exchange for one hundred thousand
(100,000) shares of our common stock. The shares are recorded as to be issued and priced at the closing price of the stock on October
27, 2014.
It is expected that HCS will incorporate their
patented technology for producing and selling high quality shrimp with our unique water treatment systems to create an intensive
indoor aquaculture farming process.
The transaction is structured as a “triangular”
merger with HCS becoming a wholly owned subsidiary of Alkame Holdings, Inc., however, after the year end, the principal of High
Country Shrimp decided to abandon the current effort and asked if Alkame would enter a joint venture to support development of
the technology through licensing of the water treatment system. The Company will provide a limited license for development of the
technology.
As of the date of this report, the Company
has abandoned this transaction and recorded an impairment of $13,500.
|
14.
|
Concentration of credit risk
|
Concentration of credit risk with
respect to trade receivables is inherent as the Company begins the ramp up of its sales. Long term, the Company does not
foresee a concentrated credit risk associated with its trade receivables. While repayment is dependent upon the financial
stability of the various customers to which shipment takes place, major customers in the water industry are typically distributors
or chain stores each with large, per shipment sales, but also with significant history and excellent credit. In the year ended
December 31, 2015, approximately 74% of sales came from two major distributors. The Company expects
these percentages to drop significantly as it expands the number and territories covered by distributors and retailers.
We have evaluated subsequent events
through the date the consolidated financial statements were available to be issued, and did not have any material recognizable
subsequent events, other than the following:
On January 12, 2016 the Company
entered into a Debt Settlement Agreement (the “Settlement Agreement”) with Erwin Vahlsing (“Vahlsing”).
Vahlsing was a creditor of the Company, having previously provided financial and accounting services to the Company. As of the
date of the Agreement, the Company owed Vahlsing $82,530.04 (the “Owed Amount”). In order to avoid litigation and extend
the time in which to repay the Owed Amount, the Settlement Agreement converted the Owed Amount into a convertible note. Pursuant
to the Settlement Agreement the Company issued to Vahlsing its convertible note in the same amount as the Owed Amount (the “Note”).
The Note provided for, among other things, 10% interest; maturity date of April 12, 2018; and, the right to convert the Note into
shares of the Company’s common stock at a discounted price. The foregoing summary of the Settlement Agreement and the Note
does not purport to be complete and is qualified in its entirety by reference to the full text of such agreement.
Stock Issuances
On February 09, 2016, the Company
issued 4,500,000 common shares upon conversion of $7,020 of accounts payable in connection with a settlement under the Section
3(a)10 of the Rules of the SEC. The shares were issued at a price of $0.00156 per share.
On February 12, 2016, the Company
issued 5,000,000 common shares upon conversion of $6,750 of convertible debt. The shares were issued at a price of $0.00135 per
share.
On February 16, 2016, the Company
issued 5,454,545 common shares upon conversion of $7,500 of convertible debt. The shares were issued at a price of $0.001385 per
share.
On February 16, 2016, the Company
issued 2,027,396 common shares upon conversion of $2,686 of convertible debt and accrued interest. The shares were issued at a
price of $0.00133 per share.
On February 17, 2016, the Company
issued 10,226,900 common shares upon conversion of $8,949 of convertible debt. The shares were issued at a price of $0.00088 per
share.
On February 18, 2016, the Company
issued 5,952,381 common shares upon conversion of $5,000 of convertible debt. The shares were issued at a price of $0.00084 per
share.
On February 22, 2016, the Company
issued 18,552,876 common shares upon conversion of $10,000 of convertible debt. The shares were issued at a price of $0.00054 per
share.
On February 22, 2016, the Company
issued 11,904,762 common shares upon conversion of $5,000 of convertible debt. The shares were issued at a price of $0.00042 per
share.
On February 22, 2016, the Company
issued 9,904,429 common shares upon conversion of $4,160 of convertible debt. The shares were issued at a price of $0.00042 per
share.
On February 23, 2016, the Company
issued 7,500,000 common shares upon conversion of $2,625 of convertible debt. The shares were issued at a price of $0.00035 per
share.
On February 24, 2016, the Company
issued 21,636,364 common shares upon conversion of $5,950 of convertible debt. The shares were issued at a price of $0.000275 per
share.
On February 25, 2016, the Company
issued 9,901,698 common shares upon conversion of $2,099 of convertible debt and accrued interest. The shares were issued at a
price of $0.000212 per share.
On February 26, 2016, the Company
issued 10,226,909 common shares upon conversion of $818 of convertible debt. The shares were issued at a price of $0.00008 per
share.
On February 29, 2016, the Company
issued 23,787,879 common shares upon conversion of $3,925 of convertible debt. The shares were issued at a price of $0.000165 per
share.
On February 29, 2016, the Company
issued 7,500,000 common shares upon conversion of $1,125 of convertible debt. The shares were issued at a price of $0.00015 per
share.
On March 1, 2016, the Company issued
9,904,429 common shares upon conversion of $1,189 of convertible debt. The shares were issued at a price of $0.00012 per share.
On March 2, 2016, the Company issued
23,852,814 common shares upon conversion of $2,755 of convertible debt. The shares were issued at a price of $0.000115 per share.
On March 7, 2016, the Company issued
21,715,522 common shares upon conversion of $1,194 of convertible debt. The shares were issued at a price of $0.000055 per share.
On March 7, 2016, the Company issued
2,102,660 common shares upon conversion of $116 of convertible debt. The shares were issued at a price of $0.000055 per share.
On March 7, 2016, the Company issued
23,818,182 common shares upon conversion of $1,310 of convertible debt. The shares were issued at a price of $0.000055 per share.
On March 8, 2016, the Company issued
9,725,791 common shares upon conversion of $195 of convertible debt. The shares were issued at a price of $0.000055 per share.
On March 10, 2016, the Company issued
9,904,429 common shares upon conversion of $594 of convertible debt. The shares were issued at a price of $0.00006 per share.
On March 10, 2016, the Company issued
23,818,182 common shares upon conversion of $1,310 of convertible debt. The shares were issued at a price of $0.000055 per share.
On March 11, 2016, the Company issued
9,725,000 common shares upon conversion of $195 of convertible debt. The shares were issued at a price of $0.00002 per share.
On March 15, 2016, the Company issued
9,904,429 common shares upon conversion of $594 of convertible debt. The shares were issued at a price of $0.00006 per share.
On March 16, 2016, the Company issued
23,818,182 common shares upon conversion of $1,310 of convertible debt. The shares were issued at a price of $0.00002 per share.
On March 17, 2016, the Company issued
16,318,490 common shares upon conversion of $865 of convertible debt. The shares were issued at a price of $0.000053 per share.
On March 18, 2016, the Company issued
9,904,429 common shares upon conversion of $594 of convertible debt. The shares were issued at a price of $0.00006 per share.
On March 23, 2016, the Company issued
20,500,000 common shares upon conversion of $12,300 of accounts payable in connection with a settlement under the Section 3(a)10
of the Rules of the SEC. The shares were issued at a price of $0.0006 per share.
On March 23, 2016, the Company issued
9,904,429 common shares upon conversion of $594 of convertible debt. The shares were issued at a price of $0.00006 per share.
On May 24, 2016, the Company issued
28,800,000 common shares upon conversion of $6,912 of accounts payable in connection with a settlement under the Section 3(a)10
of the Rules of the SEC. The shares were issued at a price of $0.00024 per share.
On June 16, 2016, the Company issued
30,250,000 common shares upon conversion of $3,630 of accounts payable in connection with a settlement under the Section 3(a)10
of the Rules of the SEC. The shares were issued at a price of $0.00012 per share.
On July 11, 2016, the Company issued
31,750,000 common shares upon conversion of $3,810 of accounts payable in connection with a settlement under the Section 3(a)10
of the Rules of the SEC. The shares were issued at a price of $0.00012 per share.
On July 25, 2016, the Company issued
33,300,000 common shares upon conversion of $3,996 of accounts payable in connection with a settlement under the Section 3(a)10
of the Rules of the SEC. The shares were issued at a price of $0.00012 per share.
On September 13, 2016, the Company
issued 35,000,000 common shares upon conversion of $4,200 of accounts payable in connection with a settlement under the Section
3(a)10 of the Rules of the SEC. The shares were issued at a price of $0.00012 per share.
On October 13, 2016, the Company
issued 36,500,000 common shares upon conversion of $4,380 of accounts payable in connection with a settlement under the Section
3(a)10 of the Rules of the SEC. The shares were issued at a price of $0.00012 per share.
On October 16, 2016, the Company
issued 36,533,396 common shares upon conversion of $1,936 of convertible debt and accrued interest. The shares were issued at a
price of $0.000053 per share.
On October 25, 2016, the Company
issued 38,500,000 common shares upon conversion of $4,620 of accounts payable in connection with a settlement under the Section
3(a)10 of the Rules of the SEC. The shares were issued at a price of $0.000106 per share.
On October 27, 2016, the Company
issued 36,687,169 common shares upon conversion of $3,889 of convertible debt and accrued interest. The shares were issued at a
price of $0.000053 per share.
On October 28, 2016, the Company
issued 42,300,000 common shares upon conversion of $7,614 of accounts payable in connection with a settlement under the Section
3(a)10 of the Rules of the SEC. The shares were issued at a price of $0.00018 per share.
On November 1, 2016, the Company
issued 46,200,000 common shares upon conversion of $8,316 of accounts payable in connection with a settlement under the Section
3(a)10 of the Rules of the SEC. The shares were issued at a price of $0.00018 per share.
On November 1, 2016, the Company
issued 19,827,273 common shares upon conversion of $2,181 of convertible debt. The shares were issued at a price of $0.00011 per
share.
On November 7, 2016, the Company
issued 32,525,312 common shares upon conversion of $3,903 of convertible debt and accrued interest. The shares were issued at a
price of $0.00012 per share.
On November 14, 2016, the Company
issued 48,500,000 common shares upon conversion of $29,100 of accounts payable in connection with a settlement under the Section
3(a)10 of the Rules of the SEC. The shares were issued at a price of $0.0006 per share.
On November 18, 2016, the Company
issued 50,900,000 common shares upon conversion of $12,216 of accounts payable in connection with a settlement under the Section
3(a)10 of the Rules of the SEC. The shares were issued at a price of $0.00024 per share.
On December 7, 2016, the Company
issued 53,500,000 common shares upon conversion of $9,630 of accounts payable in connection with a settlement under the Section
3(a)10 of the Rules of the SEC. The shares were issued at a price of $0.00018 per share.
On January 4, 2017, the Company
issued 56,100,000 common shares upon conversion of $28,050 of accounts payable in connection with a settlement under the Section
3(a)10 of the Rules of the SEC. The shares were issued at a price of $0.0005 per share.
On January 19, 2017, the Company
issued 58,900,000 common shares upon conversion of $70,680 of accounts payable in connection with a settlement under the Section
3(a)10 of the Rules of the SEC. The shares were issued at a price of $0.0012 per share.
On January 25, 2017, the Company
issued 121,212,121 common shares upon conversion of $20,000 of convertible debt. The shares were issued at a price of $0.000165
per share.
On January 26, 2017, the Company
issued 61,900,000 common shares upon conversion of $105,230 of accounts payable in connection with a settlement under the Section
3(a)10 of the Rules of the SEC. The shares were issued at a price of $0.0017 per share.
On January 31, 2017, the Company
issued 106,791,056 common shares upon conversion of $19,222 of convertible debt and accrued interest. The shares were issued at
a price of $0.00018 per share.
On February 1, 2017, the Company
issued 60,000,000 common shares upon conversion of $10,800 of convertible debt. The shares were issued at a price of $0.000185
per share.
On February 3, 2017, the Company
issued 13,949,500 common shares upon conversion of $50,218 of accounts payable in connection with a settlement under the Section
3(a)10 of the Rules of the SEC. The shares were issued at a price of $0.0036 per share.
On February 7, 2017, the Company
issued 135,000,000 common shares upon conversion of $20,308 of convertible debt. The shares were issued at a price of $0.00015
per share.
On February 7, 2017, the Company
issued 124,642,333 common shares upon conversion of $22,436 of convertible debt and accrued interest. The shares were issued at
a price of $0.00018 per share.
On February 9, 2017, the Company
issued 135,459,267 common shares upon conversion of $20,319 of convertible debt and accrued interest. The shares were issued at
a price of $0.00015 per share.
On February 10, 2017, the Company
issued 45,279,174 common shares upon conversion of $2,717 of convertible debt. The shares were issued at a price of $0.00006 per
share.
On February 16, 2017, the Company
issued 176,545,455 common shares upon conversion of $29,130 of convertible debt and accrued interest. The shares were issued at
a price of $0.000165 per share.
On February 16, 2017, the Company
issued 70,000,000 common shares upon conversion of $7,000 of convertible debt and accrued interest. The shares were issued at a
price of $0.0001 per share.
On February 17, 2017, the Company
issued 78,306,444 common shares upon conversion of $14,095 of convertible debt and accrued interest. The shares were issued at
a price of $0.00018 per share.
On February 17, 2017, the Company
issued 164,931,500 common shares upon conversion of $29,688 of convertible debt and accrued interest. The shares were issued at
a price of $0.00018 per share.
On February 17, 2017, the Company
issued 39,206,833 common shares upon conversion of $11,762 of convertible debt. The shares were issued at a price of $0.0003 per
share.
On February 17, 2017, the Company
issued 86,936,364 common shares upon conversion of $28,689 of convertible debt and accrued interest. The shares were issued at
a price of $0.00033 per share.
On February 24, 2017, the Company
issued 240,000,000 common shares upon conversion of $43,200 of convertible debt. The shares were issued at a price of $0.00018
per share.
On February 24, 2017, the Company
issued 125,000,000 common shares upon conversion of $22,500 of convertible debt. The shares were issued at a price of $0.000318
per share.
On February 28, 2017, the Company
issued 74,586,446 common shares upon conversion of $23,718 of convertible debt. The shares were issued at a price of $0.00018 per
share.
On March 1, 2017, the Company issued
108,085,525 common shares upon conversion of $40,100 of convertible debt and accrued interest. The shares were issued at a price
of $0.000371 per share.
On March 10, 2017, the Company issued
120,000,000 common shares upon conversion of $28,800 of convertible debt and accrued interest. The shares were issued at a price
of $0.00024 per share.
On March 13, 2017, the Company issued
159,978,301 common shares upon conversion of $33,915 of convertible debt and accrued interest. The shares were issued at a price
of $0.000212 per share.
On March 16, 2017, the Company issued
100,000,000 common shares upon conversion of $24,000 of accrued interest. The shares were issued at a price of $0.00024 per share.
On March 22, 2017, the Company issued
131,344,669 common shares upon conversion of $27,845 of convertible debt and accrued interest. The shares were issued at a price
of $0.000212 per share.
On March 23, 2017, the Company issued
166,666,667 common shares upon conversion of $44,700 of accrued interest. The shares were issued at a price of $0.000268 per share.
On May 19, 2017, the Company issued
171,500,000 common shares upon conversion of $44,590 of convertible debt and accrued interest. The shares were issued at a price
of $0.00026 per share.
On June 2, 2017, the Company issued
57,692,307 common shares upon conversion of $15,000 of convertible debt and accrued interest. The shares were issued at a price
of $0.00026 per share.
On June 5, 2017, the Company issued
171,153,846 common shares upon conversion of $44,500 of convertible debt and accrued interest. The shares were issued at a price
of $0.00026 per share.
On August 16, 2017, the Company
issued 122,500,000 common shares upon conversion of $14,700 of convertible debt and accrued interest. The shares were issued at
a price of $0.00026 per share.
On February 22, 2018, the Company
issued 215,000,000 common shares upon conversion of $21,500 of convertible debt and accrued interest. The shares were issued at
a price of $0.0001 per share.
On March 8, 2018, the Company issued
220,000,000 common shares upon conversion of $22,000 of convertible debt and accrued interest. The shares were issued at a price
of $0.0001 per share.
On March 23, 2018, the Company issued
135,000,000 common shares upon conversion of $13,500 of convertible debt and accrued interest. The shares were issued at a price
of $0.0001 per share.
On April 11, 2018, the Company issued
320,000,000 common shares upon conversion of $32,000 of convertible debt and accrued interest. The shares were issued at a price
of $0.0001 per share.
On May 8, 2018, the Company issued
55,000,000 common shares upon conversion of $5,500 of convertible debt and accrued interest. The shares were issued at a price
of $0.0001 per share.
On June 8, 2018, the Company issued
92,780,388 common shares in connection with a stipulated settlement agreement entered into by the Company in early 2017. The shares
were issued at a price of $0.0019 per share.
Others:
On January 19, 2016, the Company
filed an 8-K announcing the formal termination of its January 22, 2015 MOU with Ready Made, Inc. due to the inability to come to
mutually agreeable terms.
On May 10, 2016, we entered into
a Debt Exchange Agreement with Coldstream Summit Ltd. (“Coldstream”) pursuant to which we converted $1,076,125 in debt
and accrued interest held by Coldstream into 1,250,000 shares of our newly created Series E Preferred Stock in our company.
A copy of the Debt Exchange Agreement
is attached to the Current Report on Form 8-K as Exhibit 10.1 filed on May 11, 2016.
On May 10, 2016, pursuant to Article
III of our Articles of Incorporation, our Board of Directors voted to designate a class of preferred stock entitled Series E Preferred
Stock, consisting of up to 1,250,000 shares. The Certificate of Designation for the Series E Preferred Stock contains the following
features:
|
2.
|
Dividends on an as converted basis along with the holders of common stock as and when declared
by our Board of Directors;
|
|
3.
|
Rank junior to all other issued and outstanding shares of preferred stock in any liquidation;
|
|
4.
|
A liquidation preference over common stock equal to the greater of: $1.00 per share and any unpaid
dividends; and the as converted amount;
|
|
5.
|
Convertible into common stock, subject to adjustments, at a conversion price equal to a 50% discount
to the VWAP per share for the 5 trading days prior to written notice of conversion;
|
|
6.
|
Redeemable by us at $1.00 per share; and
|
|
7.
|
Protective provisions requiring prior approval to: issue additional shares of preferred stock in
an already existing and designated series; liquidate the business; pay dividends; or take any other action under Nevada law that
would require prior approval of the holders of Series E Preferred Stock.
|
The full rights afforded to the
holders of Series E Preferred Stock are defined in the relevant Certificate of Designation filed with the Nevada Secretary of State
on May 10, 2016, attached to the Current Report on Form 8-K as Exhibit 3.1 filed on May 11, 2016.
On May 10, 2016, we filed
with the Secretary of State of the State of Nevada a Certificate of Amendment to the Articles of Incorporation to increase the
authorized shares of Common Stock of our company (the “Amendment”). The Amendment authorizes us to issue 5,500,000,000
shares of Common Stock, par value $0.001 per share. The Amendment did not increase our authorized shares of Preferred Stock.
The Amendment was approved by the
board of directors by unanimous written consent resolution dated February 12, 2016 signed by all the members of the board of directors.
The Amendment was also approved by certain shareholders of the Company holding a majority of the total issued and outstanding voting
shares of the Company by written consent resolution dated February 12, 2016.
A copy of the Amendment is attached
to the Current Report on Form 8-K as Exhibit 3.2 filed on May 11, 2016.
On April 17, 2017, the Company entered
into a Stock Purchase Agreement (the “SPA”) with an accredited investor group (the “Investor” or “Buyer”).
Under the terms of the SPA, the Investor will purchase up to $550,000 of convertible debentures in a series of four tranches.
The first tranche will be in the amount of $220,000, with each of the three successive tranches in the amount of $110,000.
Each note will be issued with a
10% Original Issue Discount (“OID”) such that the net amount received by the Company will be either $200,000 or $100,000
per debenture. The convertible debentures are due and payable one year from date of issuance, and will carry interest at
a rate of 8% per annum from the date of issuance. Each debenture will be convertible into common stock of the Company at
the lower of (i) 70% of the lowest trading price of the Common Stock as reported on the OTCPK marketplace which the Company's shares
are traded or any market upon which the Common Stock may be traded in the future ("Exchange"), during the twenty (20)
trading days immediately preceding the closing date or (ii) 70% of the lowest trading price of the Common Stock as reported on
the OTCPK marketplace which the Company's shares are traded or any market upon which the Common Stock may be traded in the future
("Exchange"), during the twenty 20 trading days immediately preceding the receipt of a notice of conversion.
Subsequent funding’s after
the second tranche are conditioned on the Company completing the filing of its audits within 59 days of the date of the first funding,
and subsequent tranches will require completion of the remaining filings necessary to bring the Company current in its reporting
obligations.
Additionally, while the Notes are
outstanding, the Company is prohibited form entering into any convertible debentures or 3(A)(10) financings with another party
without prior written consent of the Buyer.
The Buyer has, for a period of 6
months from the sale of the first note purchased, to invest up to an additional $500,000, in one or more tranches, on the same
terms as those in the first four notes being purchased.
On May 1, 2017, the Company entered
into a five-year Commercial Sublease (the “Sublease”) with Bell Foods and Bell Northside, LLC. Pursuant to the Sublease,
the Property is approximately seventeen (17) acres and includes approximately twelve (12) acres of farm ground. On the remaining
five (5) acres is where the production facility is located, and the company subleased a majority portion of that processing facility.
A portion of the property has a food processing facility. The Company is required to pay $7,000 per month under the Sublease, which
increases to $10,000 per month after three months.
On the same date, the Company entered
into an Equipment Lease Agreement (the “Equipment Lease”) with Bell Foods to use certain equipment located on the property
located in the food processing facility for a nominal fee. A Letter Agreement that predated the Equipment Lease, but effective
as of May 1, 2017, was designed to supplement the Equipment Lease with an assignment by Bell Foods of its accounts receivables,
with the assumption by the Company of accounts payable, including a loan payable to Craig Bell in the sum of $150,000.
Further under the Letter Agreement,
Bell Foods was required to use the accounts receivable, prior to the effective date, to pay portions of the accounts payable. In
the event there were insufficient funds to pay off the accounts payable, Craig Bell agreed to loan additional funds to Bell Foods,
which would become part of the unpaid balance of the outstanding note.
Prior to the effective date, Bell
Foods used approximately $60,438.76 in accounts receivables to retire $60,438.76 in accounts payables, namely $49,000.00 paid to
the Craig Bell note. On the effective date, May 1, the remaining accounts receivable, valued at approximately $117,248.70, and
remaining accounts payable, valued at approximately $48,797.46, were transferred to the Company and the Company released Bell Foods
from all liability associated with the accounts payable. The company retired the remaining balance of the Craig Bell note on May
22nd.
The Company also entered into a
Wastewater Disposal Agreement, effective as of May 1, 2017, with Bell Foods, Jones Place, LLC (“Jones Place”) and Bell
Farms, Inc. This agreement concerns the right to use brine wastewater ponds that reside at the property. The Company executed this
agreement to deliver wastewater to the ponds located on the property under the specifications mandated by the Oregon Department
of Environmental Quality.
Prior to entering into these agreements,
the Company had been searching for a larger facility for increased warehousing and productions space for its water products. The
Company was also interested in the property to diversify its water product line and possibly enter into the flavored beverages
segment of the market for unique teas and health beverages. The Company believes that the foregoing agreements will afford the
Company a unique opportunity – to lease not only warehousing space, but also use the existing equipment and infrastructure
to manufacture on a “hot fill” and “healthy beverage” production line, as well as install the Company’s
bottling line, which due to added automation and redesigned layout, is expected to provide for more cost-efficient production.
As mentioned above, the Company
received a discount on the first three months’ lease cost. This was provided as an offset for removing or disposing of various
manufacturing supplies left behind from Bell Foods’ production operations.
In the Company’s original
Current Report on Form 8-K (May 8, 2017), the Company had indicated that the deal was structured as an assumption of the operations
of Bell Foods, and with it significant revenue opportunities. In fact, as stated in the Letter Agreement, the Company is simply
assisting Bell Foods close out its outstanding payables. The Company has chosen to employ several members of the previous staff
that previously worked for Bell Foods in connection with the Company’s water business.
The Company’s main focus has
always been in utilizing the patented water treatment technology for as many applications and market segments as possible, creating
more revenue streams. Growing its co-packing and private label business opportunities, and utilizing its water technology whenever
possible, should begin to grow substantially due to the new location and added capabilities the facility has. The Company may choose,
in the future, to expand its water business with hot drinks and health beverages, which the new facility is capable of providing
with added resources.
This assumption of operations
may add approximately $1.5 million in annual revenue to Alkame. In addition to the added revenue, all customers’
accounts, accounts payable and receivables, inventory, internet properties, and an extensive library of product
formulations, along with the continuation to offer private label programs and customized co-packing solutions for a selected variety
of specialty gourmet items. Along with the acquisition brings the ownership and title to the product expansion product
offerings of the brands: Everyday Gourmet Fine Foods, Everyday Organic Fine Foods, Mr. Jalapeno, and NutraBell
Gourmet Fine Foods
On October 17, 2017, the Company
entered into a nine-month convertible debenture for $16,500 with an accredited institutional investor. The debenture carries a
10% original issue discount, and interest at a rate of 8% per annum. The debenture is convertible at 70% of the lowest trading
price in the 20 trading days prior to conversion.
On October 25, 2017, the Company
entered into a nine-month convertible debenture for $27,500 with an accredited institutional investor. The debenture carries a
10% original issue discount, and interest at a rate of 8% per annum. The debenture is convertible at 70% of the lowest trading
price in the 20 trading days prior to conversion.
On October 30, 2017, the Company
entered into a nine-month convertible debenture for $22,000 with an accredited institutional investor. The debenture carries a
10% original issue discount, and interest at a rate of 8% per annum. The debenture is convertible at 70% of the lowest trading
price in the 20 trading days prior to conversion.
On November 5, 2017, the Company
entered into a nine-month convertible debenture for $22,000 with an accredited institutional investor. The debenture carries a
10% original issue discount, and interest at a rate of 8% per annum. The debenture is convertible at 70% of the lowest trading
price in the 20 trading days prior to conversion.
On November 9, 2017, the Company
entered into a nine-month convertible debenture for $90,000 with an accredited institutional investor. The debenture carries a
10% original issue discount, and interest at a rate of 8% per annum. The debenture is convertible at 70% of the lowest trading
price in the 20 trading days prior to conversion.
On January 3, 2018, the Company
entered into a nine-month convertible debenture for $30,000 with an accredited institutional investor. The debenture carries a
10% original issue discount, and interest at a rate of 8% per annum. The debenture is convertible at 70% of the lowest trading
price in the 20 trading days prior to conversion.
On January 13, 2018, the Company
entered into a nine-month convertible debenture for $22,000 with an accredited institutional investor. The debenture carries a
10% original issue discount, and interest at a rate of 8% per annum. The debenture is convertible at 70% of the lowest trading
price in the 20 trading days prior to conversion.
On February 16, 2018, the Company
entered into a nine-month convertible debenture for $55,000 with an accredited institutional investor. The debenture carries a
10% original issue discount, and interest at a rate of 8% per annum. The debenture is convertible at 70% of the lowest trading
price in the 20 trading days prior to conversion.
On February 23, 2018, the Company
entered into a nine-month convertible debenture for $55,000 with an accredited institutional investor. The debenture carries a
10% original issue discount, and interest at a rate of 8% per annum. The debenture is convertible at 70% of the lowest trading
price in the 20 trading days prior to conversion.
On February 26, 2018, the Company
entered into a nine-month convertible debenture for $55,000 with an accredited institutional investor. The debenture carries a
10% original issue discount, and interest at a rate of 8% per annum. The debenture is convertible at 70% of the lowest trading
price in the 20 trading days prior to conversion.
On March 8, 2018, the Company
entered into a nine-month convertible debenture for $55,000 with an accredited institutional investor. The debenture carries a
10% original issue discount, and interest at a rate of 8% per annum. The debenture is convertible at 70% of the lowest trading
price in the 20 trading days prior to conversion.
On March 15, 2018, the Company
entered into a nine-month convertible debenture for $22,000 with an accredited institutional investor. The debenture carries a
10% original issue discount, and interest at a rate of 8% per annum. The debenture is convertible at 70% of the lowest trading
price in the 20 trading days prior to conversion.
On March 30, 2018, the Company
entered into a 30-Day convertible debenture for $33,000 with an accredited institutional investor. The debenture carries a 10%
original issue discount, and interest at a rate of 8% per annum. The debenture was repaid prior to 30-day periods expiration.
On May 16, 2018, the Company
entered into a one-month, secured note for $50,000 with an accredited investor. The note carries 13.5% interest and was repaid
prior to its due date.
On June 6, 2018, the Company
entered into a one-month, secured note for $50,000 with an accredited investor. The note carries 12.5% interest and is due July
6, 2018.
On June 8, 2018, the Company
entered into a nine-month convertible debenture for $55,000 with an accredited institutional investor. The debenture carries a
10% original issue discount, and interest at a rate of 8% per annum. The debenture is convertible at 70% of the lowest trading
price in the 20 trading days prior to conversion.